var title_f41_37_42576="Assisted knee flexion PI";
var content_f41_37_42576=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F73144&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F73144&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Assisted knee flexion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sit on the floor with the legs extended in front of the body. Place the hands behind the injured thigh, bend the knee and pull it towards the chest, keeping the back straight. Hold for 5 seconds then straighten leg. Repeat 10 to 15 times (one set). Perform a total of 3 sets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42576=[""].join("\n");
var outline_f41_37_42576=null;
var title_f41_37_42577="L-Lysine: Drug information";
var content_f41_37_42577=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   L-Lysine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F189411\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lysinyl [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F189416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Nutritional Supplement",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F189412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Supplement: 334-1500 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prevention of recurrent herpes simplex infection: 500-3000 mg/day; begin treatment during early stage of recurrence",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F189413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F189407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lysinyl: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder, oral:  (100 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lysinyl:  (150 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 500 mg, 1000 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F189400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F189408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Improves utilization of vegetable proteins; prevention of recurrent herpes simplex infection",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13494881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     L-lysine crosses the placenta in humans (Ronzoni, 1999; Schneider, 1979). Lysine is an essential amino acid. The RDA for lysine is increased in pregnant women (IOM, 2005).",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13494882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lysine is an essential amino acid and is found in breast milk. The RDA for lysine is increased in breast-feeding women (IOM, 2005).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Lysine Acetate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $3.52",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Griffith RS, Walsh DE, Myrmel KH, et al, \"Success of L-Lysine Therapy in Frequently Recurrent Herpes Simplex Infection. Treatment and Prophylaxis,\"",
"      <i>",
"       Dermatologica",
"      </i>",
"      , 1987, 175(4):183-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/37/42577/abstract-text/3115841/pubmed\" id=\"3115841\" target=\"_blank\">",
"        3115841",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients)",
"      </i>",
"      , Washington, DC: The National Academies Press, 2005.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      \"L-lysine,\"",
"      <i>",
"       Altern Med Rev",
"      </i>",
"      , 2007, 12(2):169-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/37/42577/abstract-text/17604462/pubmed\" id=\"17604462\" target=\"_blank\">",
"        17604462",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ronzoni S, Marconi AM, Cetin I, et al, \"Umbilical Amino Acid Uptake at Increasing Maternal Amino Acid Concentrations: Effect of a Maternal Amino Acid Infusate,\"",
"      <i>",
"       Am J Obstet Gynecol",
"      </i>",
"      , 1999, 181(2):477-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/37/42577/abstract-text/10454703/pubmed\" id=\"10454703\" target=\"_blank\">",
"        10454703",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schneider H, M&ouml;hlen KH, and Dancis J, \"Transfer of Amino Acids Across the",
"      <i>",
"       in vitro",
"      </i>",
"      Perfused Human Placenta,\"",
"      <i>",
"       Pediatr Res",
"      </i>",
"      , 1979, 13(4 Pt 1):236-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/37/42577/abstract-text/471582/pubmed\" id=\"471582\" target=\"_blank\">",
"        471582",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10114 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-07BE0D3610-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42577=[""].join("\n");
var outline_f41_37_42577=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189411\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189416\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189412\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189413\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189407\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189400\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189408\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13494881\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13494882\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323324\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10114\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10114|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_37_42578="Linear skull fracture x-ray";
var content_f41_37_42578=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83505&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83505&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 617px\">",
"   <div class=\"ttl\">",
"    Linear skull fracture plain x-ray",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 597px; height: 341px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The plain films of the skull in the AP Towne's view (A) and lateral view (B) reveal a linear fracture of the right occipital bone (arrows A). The lateral view shows the fracture involving the parietal bone as well (arrows B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Yochum TR, Rowe LJ. Yochum And Rowe's Essentials of Skeletal Radiology, Third Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42578=[""].join("\n");
var outline_f41_37_42578=null;
var title_f41_37_42579="Shoulder bursitis US PMR";
var content_f41_37_42579=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F86316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F86316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 638px\">",
"   <div class=\"ttl\">",
"    Sonogram of shoulder bursitis in polymyalgia rheumatica",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 618px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left panel shows an anterior longitudinal sonogram of the shoulder in a patient with polymyalgia rheumatica. Fluid is present within the distended subacromial-subdeltoid bursa (*). The right panel shows an anterior transverse sonogram of the same shoulder, with power Doppler signals indicating active inflammation of the bursal sheaths (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of George AW Bruyn, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42579=[""].join("\n");
var outline_f41_37_42579=null;
var title_f41_37_42580="Signs and symptoms of magnesium depletion";
var content_f41_37_42580=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Signs and symptoms of magnesium depletion",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42580/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42580/contributors\">",
"     Zalman S Agus, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42580/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42580/contributors\">",
"     Stanley Goldfarb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42580/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42580/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/37/42580/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H23491151\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomagnesemia is a common problem, occurring in nearly 12 percent of hospitalized patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/1\">",
"     1",
"    </a>",
"    ]. A higher incidence, as much as 60 to 65 percent, has been found among intensive care unit patients.",
"   </p>",
"   <p>",
"    Symptomatic magnesium depletion is often associated with multiple biochemical abnormalities such as hypokalemia, hypocalcemia, and metabolic alkalosis. As a result, it is often difficult to ascribe specific clinical manifestations solely to hypomagnesemia.",
"   </p>",
"   <p>",
"    This topic reviews the signs and symptoms of magnesium depletion. The diagnosis and treatment of magnesium depletion are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/63/11254?source=see_link\">",
"     \"Evaluation and treatment of hypomagnesemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NEUROMUSCULAR",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1960, five patients were reported with symptoms considered to be typical of magnesium depletion including tetany, positive Chvostek and Trousseau signs, and generalized convulsions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/2\">",
"     2",
"    </a>",
"    ]. Somewhat similar findings &mdash; generalized weakness, anorexia, hypokalemia, hypocalcemia, and positive Trousseau and Chvostek signs &mdash; were noted when magnesium depletion was induced in normal volunteers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, apathy, delirium and coma may occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tetany can occur in the absence of hypocalcemia and alkalosis and is presumably due to lowering of the threshold for nerve stimulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In neonates and in children, hypomagnesemia is considered a cause of seizures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HYPOKALEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypokalemia is a common event in hypomagnesemic patients, occurring in 40 to 60 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/8\">",
"     8",
"    </a>",
"    ]. This relationship is in part due to underlying disorders that cause both magnesium and potassium loss, such as diarrhea and diuretic therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/41/15000?source=see_link\">",
"     \"Causes of hypomagnesemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is also evidence of renal potassium wasting in hypomagnesemic patients that is due to increased potassium secretion in the loop of Henle and the cortical collecting tubule [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/3,9\">",
"     3,9",
"    </a>",
"    ]. The following sequence may explain how this might occur. Potassium secretion from the cell into the lumen in the cells of the thick ascending limb and cortical collecting tubule is mediated by ATP-inhibitable luminal potassium (ROMK) channels (",
"    <a class=\"graphic graphic_figure graphicRef75301 \" href=\"mobipreview.htm?30/62/31725\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef60693 \" href=\"mobipreview.htm?12/31/12797\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/10\">",
"     10",
"    </a>",
"    ]. Hypomagnesemia is associated with a reduction in cell magnesium concentration, which may then lead to a decline in ATP activity and, due to removal of ATP inhibition, an increase in the number of uninhibited ROMK channels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. An increase in distal sodium delivery or increased aldosterone levels may be required to increase potassium secretion since the lumen-negative potential that promotes potassium secretion is generated by sodium reabsorption (",
"    <a class=\"graphic graphic_figure graphicRef60693 \" href=\"mobipreview.htm?12/31/12797\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the very high cell potassium concentration, this change would promote potassium secretion from the cell into the lumen and enhanced urinary losses. The hypokalemia in this setting is relatively",
"    <strong>",
"     refractory",
"    </strong>",
"    to potassium supplementation and requires correction of the magnesium deficit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     BONE AND CALCIUM METABOLISM",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hypocalcemia and hypoparathyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most classical sign of severe hypomagnesemia (less than 1.0",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    0.5",
"    <span class=\"nowrap\">",
"     mmol/L,",
"    </span>",
"    or 1.2",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    is",
"    <strong>",
"     hypocalcemia",
"    </strong>",
"    . Early in vitro studies showed that a reduction in extracellular magnesium concentration stimulated the secretion of parathyroid hormone (PTH) in the absence of changes in calcium concentration. However, immunoreactive PTH levels in most hypomagnesemic-hypocalcemic patients have been either normal or low (and in some cases undetectable), indicating inappropriately low PTH secretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further evidence for a suppressive effect of hypomagnesemia on parathyroid hormone secretion is the observation that, in the majority of these patients, parenteral magnesium supplementation leads to a rapid rise in plasma PTH levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/13,15\">",
"     13,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Parathyroid hormone resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure of hormone secretion cannot explain all of the hypocalcemia, as bone resistance to PTH also plays a role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/15\">",
"     15",
"    </a>",
"    ]. Studies in isolated perfused bone have shown that magnesium depletion interferes with the generation of cyclic AMP in response to perfusion with PTH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/16\">",
"     16",
"    </a>",
"    ]. Why this occurs is not clear. It is possible that severe hypomagnesemia may interfere with G protein activation in response to PTH, thereby minimizing the stimulation of adenylate cyclase.",
"   </p>",
"   <p>",
"    Several findings suggest that PTH resistance may be of greater importance than diminished secretion in most patients. In general, PTH-induced release of calcium from bone is substantially impaired when the plasma magnesium concentration falls below 0.8",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 0.4",
"    <span class=\"nowrap\">",
"     mmol/L);",
"    </span>",
"    in comparison, diminished PTH secretion appears to require more severe hypomagnesemia. Furthermore, there may be a variable time course for the normalization of the different aspects of calcium and PTH metabolism in hypomagnesemic patients. In some patients, PTH secretion rises significantly earlier than correction of hypocalcemia and restoration of PTH-responsiveness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/15\">",
"     15",
"    </a>",
"    ]. This observation is compatible with a primary role for PTH resistance.",
"   </p>",
"   <p>",
"    As noted above, symptomatic hypocalcemia is almost always associated with plasma magnesium levels below 1.0",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (0.5",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    or 1.2",
"    <span class=\"nowrap\">",
"     mg/dL).",
"    </span>",
"    Mild hypomagnesemia (plasma magnesium concentration between 1.1 and 1.3",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    can also lower the plasma calcium concentration, but the change is quite small (0.2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 0.05",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Vitamin D deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low plasma levels of calcitriol (1,25-dihydroxyvitamin D, the most active metabolite of vitamin D) have been noted in hypocalcemic, hypomagnesemic subjects and can contribute to the fall in the plasma calcium concentration. Why this occurs is not clear since, in one study, several days of magnesium replacement normalized plasma calcium and PTH levels but not the concentration of calcitriol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Normomagnesemic magnesium depletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small number of patients have been reported with hypocalcemia responsive to magnesium administration in the",
"    <strong>",
"     absence",
"    </strong>",
"    of detectable hypomagnesemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/15,19,20\">",
"     15,19,20",
"    </a>",
"    ]. In most of these patients, other tests suggested the presence of magnesium depletion, such as alcoholism or diarrhea. In a prospective study of 82 patients with alcohol-related admission diagnoses, for example, 30 had unexplained hypocalcemia (8.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 2.0",
"    <span class=\"nowrap\">",
"     mmol/L);",
"    </span>",
"    14 were hypomagnesemic while 16 had a normal plasma magnesium concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/20\">",
"     20",
"    </a>",
"    ]. However, both of the hypocalcemic groups had low mononuclear cell magnesium levels, a finding also seen in normocalcemic patients, and both groups showed normalization of the plasma calcium concentration after the administration of 32 to 64 meq of elemental magnesium per day for three to five days.",
"   </p>",
"   <p>",
"    These findings, however, do not conclusively demonstrate that intracellular magnesium depletion is the cause of unexplained hypocalcemia in patients with a normal plasma magnesium concentration. Most patients with chronic alcoholism and diarrhea have tissue magnesium depletion that is independent of the presence or absence of hypocalcemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/21\">",
"     21",
"    </a>",
"    ]. Sepsis, hypoalbuminemia, stress, and vitamin D deficiency are among the many factors in these patients that can lower the total and ionized calcium. Furthermore, there were no untreated time controls in this study and it is possible that resolution of the hypocalcemia may have occurred without magnesium repletion as the clinical status of the patients improved after admission. Nevertheless, it seems reasonable to consider a trial of magnesium replacement in patients with normal renal function who have persistent, unexplained hypocalcemia and are at risk for magnesium deficiency. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/63/11254?source=see_link\">",
"     \"Evaluation and treatment of hypomagnesemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     HEART AND CARDIOVASCULAR SYSTEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnesium depletion can induce changes in the electrocardiogram. Widening of the QRS complex and peaking of T waves have been described with modest magnesium loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/22\">",
"     22",
"    </a>",
"    ], while more severe magnesium depletion can lead to prolongation of the PR interval, progressive widening of the QRS complex, and diminution of the T wave [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42580/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical disturbance of greatest potential importance, however, is the association of hypomagnesemia with ventricular arrhythmias, particularly during myocardial ischemia or cardiopulmonary bypass. A discussion of these issues can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16085?source=see_link\">",
"     \"Significance of hypomagnesemia in cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3981645\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypomagnesemia occurs in nearly 12 percent of hospitalized patients and as much as 60 to 65 percent of intensive care unit patients. (See",
"      <a class=\"local\" href=\"#H23491151\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Signs and symptoms of magnesium depletion include generalized weakness, anorexia, and positive Trousseau and Chvostek signs. Apathy, delirium, coma and in neonates and children, generalized convulsions, may occur. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Neuromuscular'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypokalemia occurs in 40 to 60 percent of hypomagnesemic patients, in part due to occurrence of underlying disorders that cause both magnesium and potassium loss, such as diuretic therapy and diarrhea. Hypokalemia may also be due to renal potassium wasting that is caused by hypomagnesemia and requires correction of the magnesium deficit to correct. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Hypokalemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypocalcemia is a sign of severe hypomagnesemia (less than 1.0",
"      <span class=\"nowrap\">",
"       meq/L,",
"      </span>",
"      0.5",
"      <span class=\"nowrap\">",
"       mmol/L,",
"      </span>",
"      or 1.2",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      and is due to both inhibition of parathyroid hormone (PTH) secretion and bone resistance to PTH. Low plasma levels of calcitriol (1,25-dihydroxyvitamin D) may contribute to hypocalcemia. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Bone and calcium metabolism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypocalcemia that is responsive to magnesium administration in the",
"      <strong>",
"       absence",
"      </strong>",
"      of detectable hypomagnesemia may occur in a small number of patients. Most such patients will have an underlying cause of magnesium depletion such as alcoholism or diarrhea. A trial of magnesium replacement may be considered for patients with normal renal function who have persistent, unexplained hypocalcemia and are at risk for magnesium deficiency. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Normomagnesemic magnesium depletion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypomagnesemia is associated with ventricular arrhythmias, particularly during myocardial ischemia or cardiopulmonary bypass. Modest magnesium depletion can cause widening of the QRS complex and peaking of T waves. More severe magnesium depletion can lead to prolongation of the PR interval, progressive widening of the QRS complex, and diminution of the T wave. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Heart and cardiovascular system'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/1\">",
"      Agus ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10:1616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/2\">",
"      VALLEE BL, WACKER WE, ULMER DD. The magnesium-deficiency tetany syndrome in man. N Engl J Med 1960; 262:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/3\">",
"      Shils ME. Experimental human magnesium depletion. Medicine (Baltimore) 1969; 48:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/4\">",
"      Flink EB. Magnesium deficiency. Etiology and clinical spectrum. Acta Med Scand Suppl 1981; 647:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/5\">",
"      FRANKENHAEUSER B, MEVES H. The effect of magnesium and calcium on the frog myelinated nerve fibre. J Physiol 1958; 142:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/6\">",
"      Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med 2005; 20:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/7\">",
"      Lynch BJ, Rust RS. Natural history and outcome of neonatal hypocalcemic and hypomagnesemic seizures. Pediatr Neurol 1994; 11:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/8\">",
"      Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA 1990; 263:3063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/9\">",
"      Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 2007; 18:2649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/10\">",
"      Nichols CG, Ho K, Hebert S. Mg(2+)-dependent inward rectification of ROMK1 potassium channels expressed in Xenopus oocytes. J Physiol 1994; 476:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/11\">",
"      Yang L, Frindt G, Palmer LG. Magnesium modulates ROMK channel-mediated potassium secretion. J Am Soc Nephrol 2010; 21:2109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/12\">",
"      Whang R, Whang DD, Ryan MP. Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 1992; 152:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/13\">",
"      Chase LR, Slatopolsky E. Secretion and metabolic efficacy of parthyroid hormone in patients with severe hypomagnesemia. J Clin Endocrinol Metab 1974; 38:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/14\">",
"      Connor TB, Toskes P, Mahaffey J, et al. Parathyroid function during chronic magnesium deficiency. Johns Hopkins Med J 1972; 131:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/15\">",
"      Rude RK, Oldham SB, Singer FR. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 1976; 5:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/16\">",
"      Freitag JJ, Martin KJ, Conrades MB, et al. Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone. J Clin Invest 1979; 64:1238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/17\">",
"      Fatemi S, Ryzen E, Flores J, et al. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J Clin Endocrinol Metab 1991; 73:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/18\">",
"      Rude RK, Adams JS, Ryzen E, et al. Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. J Clin Endocrinol Metab 1985; 61:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/19\">",
"      Lim P, Jacob E. Tissue magnesium level in chronic diarrhea. J Lab Clin Med 1972; 80:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/20\">",
"      Ryzen E, Nelson TA, Rude RK. Low blood mononuclear cell magnesium content and hypocalcemia in normomagnesemic patients. West J Med 1987; 147:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/21\">",
"      Ryzen E, Elbaum N, Singer FR, Rude RK. Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency. Magnesium 1985; 4:137.",
"     </a>",
"    </li>",
"    <li>",
"     Seelig, MS. Magnesium deficiency and cardiac dysrhythmia. In: Magnesium deficiency in pathogenesis of disease, Seelig, MS (Ed), Plenum, New York, 1980, p.219.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42580/abstract/23\">",
"      Dyckner T. Serum magnesium in acute myocardial infarction. Relation to arrhythmias. Acta Med Scand 1980; 207:59.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 848 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-197.136.42.3-0869272E05-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42580=[""].join("\n");
var outline_f41_37_42580=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3981645\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23491151\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NEUROMUSCULAR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HYPOKALEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      BONE AND CALCIUM METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hypocalcemia and hypoparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Parathyroid hormone resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Vitamin D deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Normomagnesemic magnesium depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      HEART AND CARDIOVASCULAR SYSTEM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3981645\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/848\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/848|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/62/31725\" title=\"figure 1\">",
"      Loop of Henle transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/31/12797\" title=\"figure 2\">",
"      Collecting tubule transport",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/41/15000?source=related_link\">",
"      Causes of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/63/11254?source=related_link\">",
"      Evaluation and treatment of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16085?source=related_link\">",
"      Significance of hypomagnesemia in cardiovascular disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_37_42581="Fetal hydrocephaly";
var content_f41_37_42581=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fetal hydrocephaly at 21 weeks of gestation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 298px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    All four images were obtained using transvaginal sonography.",
"    <br/>",
"    (A) Posterior coronal section showing the very large posterior horns of the lateral ventricles. In the posterior fossa a relatively normal appearing cerebellum (between arrows) and the cisterna magna are seen.",
"    <br/>",
"    (B) A more anterior section than A and also showing dilation of the lateral ventricles (Lv).",
"    <br/>",
"    (C) An axial section showing the large ventricles, the dangling choroid plexus, and the very thin cortical mantle.",
"    <br/>",
"    (D) Oblique section showing the hydrocephaly.",
"    <div class=\"footnotes\">",
"     T: thalamus; CP: choroid plexus.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ana Monteagudo, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42581=[""].join("\n");
var outline_f41_37_42581=null;
var title_f41_37_42582="Obsessive-compulsive disorder in pregnant and postpartum women";
var content_f41_37_42582=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Obsessive-compulsive disorder in pregnant and postpartum women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42582/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42582/contributors\">",
"     Shaila Misri, MD, FRCPC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42582/contributors\">",
"     Shari I Lusskin, MD, FAPA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42582/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42582/contributors\">",
"     Murray B Stein, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42582/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42582/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/37/42582/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the significance of depression and psychosis during pregnancy or postpartum have been widely recognized, obsessive-compulsive disorder (OCD) has not received as much attention. OCD may also occur during these periods and poses unique clinical challenges. Rigorous epidemiologic studies are not available, but women may be at an increased risk for OCD during or following pregnancy, including new-onset OCD, recurrence, or exacerbation of a chronic disorder illness.",
"   </p>",
"   <p>",
"    The mother's obsessional thoughts often focus on the baby, and the associated, compulsive behaviors may suggest the potential for harm to the mother or child. Though relatively rare, the risk for harm should be carefully monitored. In some cases, intervention (eg hospitalization) may be required to ensure safety.",
"   </p>",
"   <p>",
"    OCD is an often-disabling illness that is frequently difficult to treat. Partial responses to treatment are common as are subsequent relapses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/1\">",
"     1",
"    </a>",
"    ]. Presentations during pregnancy and postpartum frequently go undetected and untreated.",
"   </p>",
"   <p>",
"    This topic reviews OCD during pregnancy and postpartum. The presentation, assessment, and treatment of OCD in the general population are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=see_link\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several small, retrospective studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/2-4\">",
"     2-4",
"    </a>",
"    ] suggest that OCD may be more common among pregnant and postpartum women than in the general United States population, where the estimated one-year prevalence is between 0.5 to 2.1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The only prospective study of OCD in pregnancy found a prevalence of 1.2 percent among 497 women in their third trimester, which is comparable to the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Our clinical experience suggests that OCD is more common postpartum than during pregnancy, though research findings vary on this point [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/2,3,8-10\">",
"     2,3,8-10",
"    </a>",
"    ]. The largest of these studies found a prevalence of 4 percent among 302 postpartum women, but this study was limited by a high rate of nonparticipation (38 percent) among the randomly selected sample [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/10\">",
"     10",
"    </a>",
"    ]. Studies suggest that OCD may occur at a higher rate in the presence of postpartum depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the overwhelming majority of reported cases of postpartum OCD are women, men have been reported to develop OCD after the birth of a child [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/13\">",
"     13",
"    </a>",
"    ]. Differences between women and men in age of onset of OCD have been observed. Onset in women peaks between 20 to 29 years of age, and is most common during the childbearing years, while onset in men is highest in mid-adolescence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=see_link&amp;anchor=H2#H2\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'Epidemiology and spectrum of disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;OCD is a brain-based neurobiological disorder, but more specific knowledge about its etiology is limited. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=see_link\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .) One theory expands on the \"serotonin hypothesis\" of OCD, proposing that fluctuations in estrogen and progesterone during pregnancy and postpartum affect serotonin levels in the brain, leading to OCD symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/4,14\">",
"     4,14",
"    </a>",
"    ]. Preliminary evidence suggests that onset or worsening of OCD symptoms may be associated with fluctuations of these hormones at specific points of the female reproductive cycle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Oxytocin, a hormone that is elevated in postpartum women, also functions as a neurotransmitter; however, a relationship between postpartum oxytocin levels and OCD symptoms has not been demonstrated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=see_link&amp;anchor=H3#H3\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'Pathophysiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One hypothesis derived from cognitive-behavioral theory describes a possible path for the development of postpartum obsessions and compulsions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/4,18\">",
"     4,18",
"    </a>",
"    ]. Many new parents may experience fleeting thoughts of harming their child. An example is the thought or mental image of shaking the baby. In people with OCD these unwanted, intrusive thoughts may be assigned a heightened level of meaning and responsibility. In order to neutralize the thought, the parent engages in compulsive rituals that produce emotional relief. This conceptualization suggests that treatment with cognitive-behavioral therapy should focus on helping the patient to understand and address maladaptive beliefs they have assigned to the intrusive thoughts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Presenting features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with prepregnancy onset of OCD meet DSM-IV TR criteria for the disorder (",
"    <a class=\"graphic graphic_table graphicRef78513 \" href=\"mobipreview.htm?15/1/15387\">",
"     table 1",
"    </a>",
"    ). The obsessional thinking and compulsive behaviors often focus on the pregnancy or baby. During pregnancy, obsessions are often about fears of fetal death or contamination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. An example of contamination is a mother's belief that she is infected and if she holds her baby the infection will spread to the baby as well. Postpartum, obsessive thoughts or mental images of harming the baby are common, as are fears of contamination of the baby. Examples of aggressive thoughts or mental images include dropping the baby onto the floor, drowning the baby in the bathtub, throwing the baby out the window, crushing the baby's skull, or microwaving the baby [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/4,11,20-22\">",
"     4,11,20-22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Compulsive behaviors may include the mother's repeated requests for ultrasounds to check fetal well-being prior to birth, or subsequent avoidance of touching the baby, or subjecting the baby to repeated washing or changing. Other examples of obsessions and compulsions are listed in the table [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/3,10,11,15,19-21,23-25\">",
"     3,10,11,15,19-21,23-25",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef77826 \" href=\"mobipreview.htm?33/38/34412\">",
"     table 2",
"    </a>",
"    ). The rate at which aggressive obsessions toward the baby lead to harmful behaviors is not known, but such acts are believed to be relatively rare. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=see_link&amp;anchor=H4#H4\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'Clinical manifestations and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By definition, patients with OCD have insight into their obsessions, recognizing them as intrusive and inappropriate, though their degree of insight can vary. When severe obsessive thoughts persist over a long period of time, they can resemble fixed delusional thinking. On very rare occasions, these thoughts can progress to psychosis, where the patient believes the",
"    <span class=\"nowrap\">",
"     ideas/thoughts",
"    </span>",
"    are real. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/39/17014?source=see_link\">",
"     \"Postpartum psychosis: Epidemiology, clinical manifestations, and assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/62/29670?source=see_link\">",
"     \"Treatment of postpartum psychosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Risk of harm",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a lack of research data on patient characteristics in this population that predict harmful acts, but clinical experience suggests that risk factors include the stated intent to cause harm, psychotic thoughts, poor insight, poor impulse control, accompanying severe depression, low levels of family support, or a baby with more than usual needs. Avoidance of the baby carries a risk for neglect, with the potential for severe harm or even death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;The course of OCD during pregnancy and postpartum has not been well studied. Studies have had small samples and found mixed outcomes, with varying proportions of patients improving, worsening,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    staying the same [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/8,9,19,26\">",
"     8,9,19,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinically, we have observed that women often present for the first time with obsessional thoughts during pregnancy and postpartum, and these obsessions can occur with or without associated compulsions. Women who have new onset of OCD in the perinatal period tend to have a milder course. In our experience, among women with preexisting OCD, earlier onset and greater severity tends to be associated with a more severe course during pregnancy or postpartum. These patients typically experience their usual obsessions and compulsions with the addition of those that are baby-centered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SCREENING AND ASSESSMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although screening for OCD among pregnant and postpartum women has not been rigorously studied, based on our experience we suggest that obstetricians or primary care clinicians administer a one-question screening in the course of prenatal and postpartum care. We suggest that clinicians caring for the mother or baby similarly screen the mother for the disorder periodically during the first six months after childbirth, beginning between week two and week four. Patients with a history of OCD should be assessed more frequently. Two Illustrative screening questions include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      \"It's not uncommon for new mothers to experience intrusive, unwanted thoughts that they might harm their baby. Have any such thoughts occurred to you?\" [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Have you had any scary thoughts, for example, that you might accidentally harm the baby? Many women experience such thoughts, but are afraid to mention them.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who screen positive should receive a thorough psychiatric assessment that includes the DSM-IV TR criteria for OCD (",
"    <a class=\"graphic graphic_table graphicRef78513 \" href=\"mobipreview.htm?15/1/15387\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/28\">",
"     28",
"    </a>",
"    ]. In evaluating the patient's mental status, it is important to distinguish the obsessional thoughts of OCD from psychotic thoughts or ideas. The interviewer should explore whether the patient has insight into the false ideas and related behaviors (obsessions and compulsions) or if she believes they are real (psychosis). Patients should be asked if they have intent or desire to harm the baby, others, or themselves. Patients should be evaluated for comorbid disorders, including depression and generalized anxiety disorder.",
"   </p>",
"   <p>",
"    Whenever possible, assessment for OCD should include secondary sources of information, such as the patient's partner or a close family member. Women with OCD are often secretive about their symptoms and may be reluctant to disclose them to a clinician due to stigma, shame, or fear that disclosure would lead to the baby being taken away. We have observed that the symptoms may come to clinical attention only when the partner or other family caregiver has to return to work and is concerned about the mother's ability to care for the child on her own. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=see_link&amp;anchor=H4#H4\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'Clinical manifestations and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;OCD is a challenging disorder to treat; only 20 percent of patients are estimated to achieve a full remission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/1\">",
"     1",
"    </a>",
"    ]. Treatment of the illness in pregnant and postpartum women can be more complex, with additional risk factors to consider and little data available to inform treatment. Some general principles to guide treatment are as follows:",
"   </p>",
"   <p>",
"    When the patient's illness is accompanied by factors suggesting a risk of harm to mother or baby (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Risk of harm'",
"    </a>",
"    above), safety should be the foremost consideration. Interventions should be based on the likelihood of harm. In lower-risk situations, outpatient interventions may be sufficient, such as a partner or family members who will provide support, child care, and ensure the patient is not alone with the baby. In higher-risk circumstances, the mother may require hospitalization and intervention by the state department of child protective services may be required for the baby. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/5/35927?source=see_link\">",
"     \"Child abuse: Social and medicolegal issues\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When multiple clinicians are treating a pregnant or postpartum woman with OCD (eg, an obstetrician or primary care clinician and a mental health specialist), communication among providers is important. Patients can be selective in revealing information related to safety, treatment compliance, or changes in severity of illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Medication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications shown to be effective for treatment of OCD in the general population include the serotonergic antidepressants and, for refractory cases, augmentation with atypical antipsychotic medication. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/0/23561?source=see_link\">",
"     \"Pharmacotherapy for obsessive-compulsive disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Deciding whether or not to prescribe one of these medications for a pregnant or nursing woman should be based, as it is for all patients, on a careful weighing of the benefits and risks of treatment, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The severity and chronicity of the obsessions and compulsions, and the degree to which they impair patient and family functioning.",
"     </li>",
"     <li>",
"      The risks that untreated illness present to the mother and baby (eg, avoidance, neglect, suicidality, or homicidality).",
"     </li>",
"     <li>",
"      The risks the medications present to the baby through exposure either in utero or during breast feeding. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/0/28682?source=see_link&amp;anchor=H4#H4\">",
"       \"Depression in pregnant women: Management\", section on 'Pharmacotherapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38745?source=see_link\">",
"       \"Use of psychotropic medications in breastfeeding women\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Decision-making is made more difficult by the paucity of research on the efficacy and adverse effects of medications. Thus, the physician may want to emphasize educating the patient and partner about risks and benefits and helping them come to an informed decision. Patient preferences can vary widely and similar patients may make very different decisions.",
"   </p>",
"   <p>",
"    The efficacy of medications for OCD in pregnant or postpartum women has not been tested in randomized trials. There are no published studies of any type for the serotonergic antidepressants in this population. A single uncontrolled study examined",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    augmentation following an inadequate response to an SSRI in 17 postpartum women with OCD. After 12 weeks of treatment, 11 of the 17 women experienced a 50-percent or greater reduction in symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When comorbid postpartum depression and OCD are treated with medication, first-line treatment is a serotonergic antidepressant, which can be effective for both disorders. Treatment should aimed at remission of both OCD and depression. At the start of treatment with these medications, a benzodiazepine such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    can be used to treat the anxiety and insomnia that may accompany the disorder or develop secondary to the medication. (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38745?source=see_link\">",
"     \"Use of psychotropic medications in breastfeeding women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/0/28682?source=see_link&amp;anchor=H4#H4\">",
"     \"Depression in pregnant women: Management\", section on 'Pharmacotherapy'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Psychotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychotherapies used to treat OCD are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=see_link\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .) No placebo-controlled trials have been reported on the efficacy of psychotherapy for pregnant or postpartum women with OCD. One trial compared cognitive-behavioral therapy (CBT) and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    to paroxetine alone in 35 postpartum women with comorbid depression and anxiety disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/12\">",
"     12",
"    </a>",
"    ]. No differences were seen between the groups receiving and not receiving CBT. Results were not reported separately for the 13 patients with OCD.",
"   </p>",
"   <p>",
"    Clinical experts have suggested the use of filial therapy or infant massage as adjunctive treatment when OCD interferes with attachment and bonding between the mother and child [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42582/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Filial therapy trains the mother through instruction, demonstration play, and supervision to create positive interactions with the baby, recognizing and responding to his or her emotions in an accepting environment. Symptoms suggesting the possible utility of this approach include the mother avoiding the infant, being intrusive, or being excessively clingy. Although evaluated for numerous populations, filial therapy has not been studied specifically for OCD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obsessive-compulsive disorder (OCD) may be more prevalent among pregnant and postpartum women than in the general population, but rigorous epidemiologic research on the topic is not available. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Obsessional thoughts and compulsive behaviors in OCD during pregnancy or postpartum often concern the baby. Thoughts about contaminating or harming the baby are a common theme. Harmful behaviors are relatively rare but warrant careful assessment and intervention as needed to ensure safety. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      OCD may go undetected during prenatal or postpartum care. Obstetricians and primary care clinicians should consider routine screening during pregnancy and for several months post-delivery. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Screening and assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For mild OCD without immediate risks to the mother or child, we suggest treatment with cognitive-behavioral therapy (CBT) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Adjunctive attachment therapy may be useful if an attachment or bonding issue is present. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Psychotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment with a serotonergic antidepressant is usually necessary for women with moderate to severe OCD. The decision to use psychotropic medication while pregnant or nursing requires informed consent via a careful discussion among the physician, the patient, and her partner of the potential risks of the medication versus the potential risks of the untreated illness. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Medication'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When moderate-to-severe OCD is refractory to first-line treatment (serotonergic antidepressant), we suggest the patient and physician weigh the benefits and risks of the following options: augmentation with CBT, switching to a different class of serotonergic antidepressant, or augmentation with an atypical antipsychotic. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Medication'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Psychotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Attachment therapies may be useful in treating problems with attachment or bonding between mother and baby, although their use has not been studied for OCD. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Psychotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/1\">",
"      Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]. Arch Gen Psychiatry 1999; 56:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/2\">",
"      Wenzel A, Haugen EN, Jackson LC, Brendle JR. Anxiety symptoms and disorders at eight weeks postpartum. J Anxiety Disord 2005; 19:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/3\">",
"      Wenzel, A, et al. The occurrence of panic and obsessive compulsive symptoms in women with postpartum dysphoria: A prospective study. Arch Women Ment Health 2001; 4:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/4\">",
"      Abramowitz JS, Schwartz SA, Moore KM, Luenzmann KR. Obsessive-compulsive symptoms in pregnancy and the puerperium: a review of the literature. J Anxiety Disord 2003; 17:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/5\">",
"      Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/6\">",
"      Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988; 45:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/7\">",
"      Sutter-Dallay AL, Giaconne-Marcesche V, Glatigny-Dallay E, Verdoux H. Women with anxiety disorders during pregnancy are at increased risk of intense postnatal depressive symptoms: a prospective survey of the MATQUID cohort. Eur Psychiatry 2004; 19:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/8\">",
"      Neziroglu F, Anemone R, Yaryura-Tobias JA. Onset of obsessive-compulsive disorder in pregnancy. Am J Psychiatry 1992; 149:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/9\">",
"      Williams KE, Koran LM. Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. J Clin Psychiatry 1997; 58:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/10\">",
"      Uguz F, Akman C, Kaya N, Cilli AS. Postpartum-onset obsessive-compulsive disorder: incidence, clinical features, and related factors. J Clin Psychiatry 2007; 68:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/11\">",
"      Wisner KL, Peindl KS, Gigliotti T, Hanusa BH. Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry 1999; 60:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/12\">",
"      Misri S, Reebye P, Corral M, Milis L. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 2004; 65:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/13\">",
"      Abramowitz J, Moore K, Carmin C, et al. Acute onset of obsessive-compulsive disorder in males following childbirth. Psychosomatics 2001; 42:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/14\">",
"      Barr LC, Goodman WK, Price LH. The serotonin hypothesis of obsessive compulsive disorder. Int Clin Psychopharmacol 1993; 8 Suppl 2:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/15\">",
"      Labad J, Mench&oacute;n JM, Alonso P, et al. Female reproductive cycle and obsessive-compulsive disorder. J Clin Psychiatry 2005; 66:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/16\">",
"      Vulink NC, Denys D, Bus L, Westenberg HG. Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol 2006; 21:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/17\">",
"      Leckman JF, Goodman WK, North WG, et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology 1994; 19:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/18\">",
"      Fairbrother N, Abramowitz JS. New parenthood as a risk factor for the development of obsessional problems. Behav Res Ther 2007; 45:2155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/19\">",
"      Uguz F, Gezginc K, Zeytinci IE, et al. Course of obsessive-compulsive disorder during early postpartum period: a prospective analysis of 16 cases. Compr Psychiatry 2007; 48:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/20\">",
"      Brockington IF, Macdonald E, Wainscott G. Anxiety, obsessions and morbid preoccupations in pregnancy and the puerperium. Arch Womens Ment Health 2006; 9:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/21\">",
"      Sichel DA, Cohen LS, Dimmock JA, Rosenbaum JF. Postpartum obsessive compulsive disorder: a case series. J Clin Psychiatry 1993; 54:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/22\">",
"      Jennings KD, Ross S, Popper S, Elmore M. Thoughts of harming infants in depressed and nondepressed mothers. J Affect Disord 1999; 54:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/23\">",
"      Abramowitz JS, Nelson CA, Rygwall R, Khandker M. The cognitive mediation of obsessive-compulsive symptoms: a longitudinal study. J Anxiety Disord 2007; 21:91.",
"     </a>",
"    </li>",
"    <li>",
"     Buttolph, M. Obsessive-compulsive disorders in pregnancy and childbirth, in Obsessive Compulsive Disorders, Theory and Management, 2nd Ed, Jenike, M, Baer, L, Minichiello, WE (Eds), Yearbook Medical Publishers, Chicago 1990.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/25\">",
"      Sichel DA, Cohen LS, Rosenbaum JF, Driscoll J. Postpartum onset of obsessive-compulsive disorder. Psychosomatics 1993; 34:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/26\">",
"      Uguz F, Kaya N, Sahingoz M, et al. One year follow-up of postpartum-onset obsessive-compulsive disorder: a case series. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/27\">",
"      Brandes M, Soares CN, Cohen LS. Postpartum onset obsessive-compulsive disorder: diagnosis and management. Arch Womens Ment Health 2004; 7:99.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association Task Force on DSM-IV, Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/29\">",
"      Misri S, Milis L. Obsessive-compulsive disorder in the postpartum: open-label trial of quetiapine augmentation. J Clin Psychopharmacol 2004; 24:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/30\">",
"      Rennie, R, Landreth, G. Effects of filial therapy on parent and child behaviors. International Journal of Play Therapy 2000; 9:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42582/abstract/31\">",
"      Lee HK. The effects of infant massage on weight, height, and mother-infant interaction. Taehan Kanho Hakhoe Chi 2006; 36:1331.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 504 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-340D2F8564-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42582=[""].join("\n");
var outline_f41_37_42582=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Presenting features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Risk of harm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SCREENING AND ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      General principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Medication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/504\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/504|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/1/15387\" title=\"table 1\">",
"      Diagnostic criteria for obsessive-compulsive disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/38/34412\" title=\"table 2\">",
"      Obsessions and compulsions in pregnancy or postpartum",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/5/35927?source=related_link\">",
"      Child abuse: Social and medicolegal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/0/28682?source=related_link\">",
"      Depression in pregnant women: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36564?source=related_link\">",
"      Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/0/23561?source=related_link\">",
"      Pharmacotherapy for obsessive-compulsive disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/39/17014?source=related_link\">",
"      Postpartum psychosis: Epidemiology, clinical manifestations, and assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/62/29670?source=related_link\">",
"      Treatment of postpartum psychosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38745?source=related_link\">",
"      Use of psychotropic medications in breastfeeding women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_37_42583="Overview of dual-energy x-ray absorptiometry";
var content_f41_37_42583=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of dual-energy x-ray absorptiometry",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42583/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42583/contributors\">",
"     E Michael Lewiecki, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42583/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42583/contributors\">",
"     Clifford J Rosen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42583/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42583/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/37/42583/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoporosis or low bone mass (osteopenia) occurs in about 44 million American men and women, accounting for 55 percent of the population age 50 and over [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/1\">",
"     1",
"    </a>",
"    ]. Osteoporosis has been defined as \"a skeletal disease characterized by compromised bone strength predisposing a person to an increased risk of fracture\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are approximately two million fragility fractures in the US each year: 547,000 vertebral fractures, 297,000 hip fractures, 397,000 wrist fractures, and 675,000 at other skeletal sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/3\">",
"     3",
"    </a>",
"    ]. Fractures of the spine and hip are associated with chronic pain, deformity, depression, disability, and death. About 50 percent of patients with hip fractures will never be able to walk without assistance and 25 percent will require long-term care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/4\">",
"     4",
"    </a>",
"    ]. The mortality rate five years after a fracture of the hip or a clinical vertebral fracture is about 20 percent greater than expected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/5\">",
"     5",
"    </a>",
"    ]. The direct cost of incident osteoporotic fractures in the US was about $17 billion per year in 2005 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss the clinical applications and interpretation of dual-energy x-ray absorptiometry (DXA) in evaluating osteoporosis. Other aspects of screening for osteoporosis are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/28/40393?source=see_link\">",
"     \"Screening for osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BONE QUALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone strength is determined by bone mineral density (BMD) and other properties of bone that are often collectively called \"bone quality\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/6\">",
"     6",
"    </a>",
"    ]. Non-BMD determinants of bone strength include bone turnover, architecture (size and shape, or bone geometry), microarchitecture (eg, trabecular thickness, trabecular connectivity, trabecular perforation, cortical thickness, and cortical porosity), damage accumulation, matrix properties, mineralization, and mineral properties (eg, crystal size and orientation).",
"   </p>",
"   <p>",
"    Investigation of bone quality has provided insight into the pathogenesis of osteoporosis and a better understanding of the mechanism of action of medications used to treat osteoporosis, but with the exception of bone turnover markers it is not yet possible to measure these routinely in clinical practice. MICRO CT and MR techniques that can discern individual trabeculae are being developed commercially and may be available for clinical use in the next few years. For now, in the absence of a fragility fracture, bone density is the best predictor of fracture risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     BMD testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;BMD testing is a widely available clinical tool to diagnose osteoporosis, predict fracture risk, and monitor response to therapy. While BMD testing at any skeletal site with a variety of technologies can predict fracture risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/7\">",
"     7",
"    </a>",
"    ], dual-energy x-ray absorptiometry (DXA) of the spine, hip, and forearm is the only method for diagnosis of osteoporosis in the absence of a fragility fracture and the best method for monitoring changes in BMD over time for a number of reasons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biomechanical studies have shown a strong correlation between mechanical strength and BMD measured by DXA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In prospective cohort studies, there is a strong relationship between fracture risk and BMD measured by DXA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The World Health Organization (WHO) criteria for the diagnosis of osteoporosis and for input into the fracture risk algorithm (FRAX) are based on reference data obtained by DXA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link&amp;anchor=H4#H4\">",
"       \"Osteoporotic fracture risk assessment\", section on 'Fracture risk assessment tool'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Randomized clinical trials showing a reduction in fracture risk with drug therapy have selected subjects based on BMD measured by DXA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is a relationship between decreased fracture risk with drug therapy and increases in BMD measured by DXA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/13\">",
"       13",
"      </a>",
"      ]. However, the magnitude of fracture risk reduction that is attributable to increases in BMD is variable.",
"     </li>",
"     <li>",
"      Accuracy and precision are excellent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/14\">",
"       14",
"      </a>",
"      ]; radiation exposure is very low [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DXA TECHNOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A typical DXA instrument consists of a padded table on which the patient lies and a movable C-arm with an x-ray tube below the patient and a detector above the patient (",
"    <a class=\"graphic graphic_figure graphicRef59225 \" href=\"mobipreview.htm?28/60/29646\">",
"     figure 1",
"    </a>",
"    ). The x-ray tube generates photon beams of two different energy levels, thus the term \"dual-energy.\" A collimator below the table limits the scatter of the photons and directs them toward the area of interest. The difference in attenuation (reduction in intensity) of the two photon beams as they pass through body tissue of variable composition distinguishes bone from soft tissue and allows quantification of BMD. Denser and thicker tissue contains more electrons and allows fewer photons to pass through to the detector. A computer with specially designed proprietary software designed by each manufacturer completes the DXA \"system.\"",
"   </p>",
"   <p>",
"    Radiation exposure to the patient is very small, usually of a similar magnitude to daily background radiation. Radiation scatter beyond the edge of the DXA table is negligible. No shielding of the technologist or the room is necessary. As a safety precaution, the technologist should typically not sit within three feet of the table edge while the patient is being scanned.",
"   </p>",
"   <p>",
"    DXA measures bone mineral content (BMC, in grams) and bone area (BA, in square centimeters), then calculates \"areal\" BMD in",
"    <span class=\"nowrap\">",
"     g/cm2",
"    </span>",
"    by dividing BMC by BA. T-score, the value used for diagnosis of osteoporosis, is calculated by subtracting the mean BMD of a young-adult reference population from the patient's BMD and dividing by the standard deviation (SD) of young-adult population. Z-score, used to compare the patient's BMD to a population of peers, is calculated by subtracting the mean BMD of an age-, ethnicity-, and sex-matched reference population from the patient's BMD and dividing by the SD of the reference population. The mean BMD and SD of the reference populations used for these calculations is a critical variable in the determination of T-scores and Z-scores. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/55/11128?source=see_link&amp;anchor=H8#H8\">",
"     \"Diagnosis and evaluation of osteoporosis in postmenopausal women\", section on 'T-score'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/55/11128?source=see_link&amp;anchor=H9#H9\">",
"     \"Diagnosis and evaluation of osteoporosis in postmenopausal women\", section on 'Z-score'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are significant differences in the technologies used by different manufacturers and sometimes different models of DXA made by the same manufacturer. Manufacturers use different methods for creating dual photon beams (eg, K-edge filtering and voltage switching), different bone edge detection algorithms, different assumptions on body size and tissue composition, different calibration, and different types of photon detectors. Photon beams have different configurations, eg, pencil beam and fan beam. The bone regions of interest (ROI) measured may be different, especially so with the femoral neck. The reference databases used to calculate T-scores and Z-scores may be different. For all of these reasons, it is not possible to make quantitative comparisons of BMD measured on different instruments, especially those made by different manufacturers, unless a cross-calibration study has been done [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATIONS OF DXA",
"    </span>",
"    &nbsp;&mdash;&nbsp;DXA is used to diagnose osteoporosis or low BMD, estimate the future risk of fracture, and monitor changes in BMD over time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guidelines or evidence-based reviews on the indications for BMD testing have been published by many organizations and are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/28/40393?source=see_link&amp;anchor=H14#H14\">",
"     \"Screening for osteoporosis\", section on 'Recommendations by expert groups'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The guidelines vary according to the populations addressed, clinical risk factors considered, definition of fragility fracture, methodologies used, and weighting of levels of medical evidence versus expert opinion. Of all the published guidelines, those of the National Osteoporosis Foundation are the most comprehensive and perhaps the most useful in clinical practice (",
"    <a class=\"graphic graphic_table graphicRef58752 \" href=\"mobipreview.htm?32/48/33547\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;DXA should not be done in women who are pregnant or may be pregnant because ionizing radiation, albeit it in very small doses, is used. DXA should be postponed until pregnancy is completed. As with any medical test, DXA should not be done unless the results are likely to play a role in the management of the patient. It may not be possible to do a DXA of the hip and spine in some patients due to inability to get on the table. BMD measurement may not be valid in some situations due to skeletal structural abnormalities, such as severe osteoarthritis, surgical hardware, or scoliosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Skeletal site selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization (WHO) recommends that the international standard for diagnosis of osteoporosis be made using the T-score measured by DXA at the femoral neck [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/17\">",
"     17",
"    </a>",
"    ]. However, the NOF and the International Society for Clinical Densitometry (ISCD) suggest that the diagnosis of osteoporosis in clinical practice be made by DXA using the lowest T-score of the lumbar spine (L1-L4), total proximal femur, or femoral neck [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/1,18\">",
"     1,18",
"    </a>",
"    ]. In the hip, Ward's area, trochanter, and other regions of interest (ROIs) should not be used for diagnosis. If the forearm is measured, then the 33 percent radius (one-third radius) may be used for diagnostic purposes if it is the lowest of the skeletal sites measured.",
"   </p>",
"   <p>",
"    The rationale for using the lowest T-score of these skeletal sites is that all are good predictors of fracture risk, and the use of the lumbar spine, hip, and forearm BMD is consistent with the original WHO diagnostic classification of 1994 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest following NOF recommendations (DXA of the lumbar spine and hip). We make the diagnosis according to the lowest T-score measured. Skeletal site selection is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link&amp;anchor=H16#H16\">",
"     \"Osteoporotic fracture risk assessment\", section on 'Skeletal site to measure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Reference databases",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO recommends calculation of T-score with a uniform, standardized reference database in men and women of all ethnic groups, using the NHANES III database for femoral neck measurements in young-adult Caucasian women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/17\">",
"     17",
"    </a>",
"    ]. The ISCD also recommends the use of the NHANES III young-adult Caucasian database for calculation of hip T-score in all ethnic groups, but with use of a female database for women and a male database for men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/18\">",
"     18",
"    </a>",
"    ]. The reference database for calculation of Z-score is matched for age, ethnicity, and sex.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Diagnosis of osteoporosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A clinical diagnosis of osteoporosis may be made in the presence of a fragility fracture, regardless of BMD. A fragility fracture has been defined variously as one that occurs after a fall from the standing position or one that is associated with low BMD and increases in incidence with age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/19\">",
"     19",
"    </a>",
"    ]. It is preferable to diagnose osteoporosis before the first fracture occurs, just as it is preferable to diagnose hypertension before a stroke or hypercholesterolemia before a myocardial infarction. The WHO has established a classification of BMD according to T-score that has been adapted for clinical use by the ISCD (",
"    <a class=\"graphic graphic_table graphicRef53999 \" href=\"mobipreview.htm?6/54/7019\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/8,11\">",
"     8,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Postmenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO classification of BMD may be applied to perimenopausal and postmenopausal women of all ethnicities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/8\">",
"     8",
"    </a>",
"    ]. The WHO selected a T-score of -2.5 or less to define osteoporosis because this identified about 30 percent of postmenopausal Caucasian women as having osteoporosis, which is approximately the same as the lifetime risk of fragility fracture in this population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Premenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO classification should not be used in healthy premenopausal women, because the relationship between BMD and fracture risk is not well established in this population. Z-scores, not T-scores, should be used in premenopausal women. A clinical diagnosis of osteoporosis may be made in the presence of a fragility fracture, or when there is low BMD and risk factors for fracture, such as long-term glucocorticoid therapy or hyperparathyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/25/6553?source=see_link\">",
"     \"Epidemiology and etiology of premenopausal osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Men",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO classification may be used in men age 50 and older [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/17\">",
"     17",
"    </a>",
"    ]. In younger men, as with premenopausal women, Z-scores, not T-scores, should be used, and a clinical diagnosis of osteoporosis may be made in the presence of a fragility fracture, or when there is low BMD and risk factors for fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO classification should not be used in children and adolescents. The diagnosis of osteoporosis in children and adolescents cannot be made based on densitometric criteria alone; it requires the presence of both a clinically significant fracture history and low bone mineral content (BMC) or bone mineral density (BMD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A clinically significant fracture history is one or more of the following: long bone fracture of the lower extremities, vertebral compression fracture, or two or more long bone fractures of the upper extremities. Low bone mineral content or bone mineral density is defined as a BMC or areal BMD Z-score that is less than or equal to -2.0, adjusted for age, gender, and body size, as appropriate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/22\">",
"     22",
"    </a>",
"    ]. Z-scores, not T-scores, should be used, since it is not appropriate to compare the BMD of someone who has not yet achieved peak bone mass to an adult who has.",
"   </p>",
"   <p>",
"    BMD measurement in children and adolescents is confounded by factors that include the lack of standardized reference databases for calculating Z-scores [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/21\">",
"     21",
"    </a>",
"    ], changes in bone size with growth, and variability in the relationships between BMD and chronological age, sexual maturation, and bone age. When technically feasible, patients should have measurements of spine and total body less head (TBLH) BMC and areal BMD prior to initiation of bone active treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/22\">",
"     22",
"    </a>",
"    ]. The hip (ie, total hip and proximal femur) is not a reliable site for measurement in growing children due to significant variability in skeletal development and lack of reproducible regions of interest. An appropriate reference data set for calculation of Z-score must include a sample of the general healthy population sufficiently large to characterize the normal variability in bone measures that takes into consideration gender, age, and",
"    <span class=\"nowrap\">",
"     race/ethnicity.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Serial BMD testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeat BMD testing is recommended for patients being treated for osteoporosis, with the goal of stabilizing or increasing BMD, and for patients not being treated, in whom evidence of bone loss would lead to treatment. Serial BMD tests showing a change or stability of BMD may provide helpful clinical information, assuming the comparisons are technically valid and the clinician is knowledgeable regarding clinical implications. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Validity of comparisons'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Whenever possible, the same instrument should be used for serial DXA studies. Comparison of BMD measured with different instruments made by the same manufacturer or by a different manufacturer is discouraged for the reasons noted above. It is not possible to quantify BMD changes on measurements made on different instruments unless a cross-calibration study has been done. Comparison should be done using BMD in",
"    <span class=\"nowrap\">",
"     g/cm2,",
"    </span>",
"    not T-score, since changes in reference databases with software upgrades may cause spurious T-score changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Precision assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The least significant change (LSC) with a 95 percent level of confidence should be established at each bone densitometry center for each technologist by in-vivo precision assessment according to well-established guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/23\">",
"     23",
"    </a>",
"    ]. LSC is defined as a change that is 2.77 times the precision error for each measured skeletal site, for each technologist, and it is best expressed as an absolute value",
"    <span class=\"nowrap\">",
"     (g/cm2).",
"    </span>",
"    Values for precision error supplied by the manufacturer of the DXA instrument are generally better than what is achievable in bone densitometry centers and should not be used for the calculation of LSC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Time interval for repeating DXA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeat BMD testing may be considered when the results are likely to influence clinical management, such as when the expected amount of change in bone density equals or exceeds the LSC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/18,23\">",
"     18,23",
"    </a>",
"    ]. Consider repeat BMD testing one or two years after starting pharmacological therapy, as soon as six months after starting glucocorticoid therapy, or perhaps never if very little change is expected or the results of testing are unlikely to influence patient management decisions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Skeletal site to monitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best skeletal site to monitor is one that responds quickly to therapy or lack of therapy and has a low LSC. Usually this is the lumbar spine. If the lumbar spine is not evaluable, as may occur with degenerative arthritis in elderly patients, then the total proximal femur should be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Validity of comparisons",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comparison of BMD measured with different instruments made by the same manufacturer or by a different manufacturer is discouraged for the reasons noted above. Comparison should be done using BMD in",
"    <span class=\"nowrap\">",
"     g/cm2,",
"    </span>",
"    not T-score, since changes in reference databases may cause spurious T-score changes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/24\">",
"     24",
"    </a>",
"    ]. Images of the skeletal site being compared should be carefully examined to assure correct positioning, labeling, and identification of bone edges. If the lumbar spine is being compared, then the vertebral levels must be labeled in the same way. If hip or forearm is being compared, the same ROI on the same side must be used. Bone area being compared must be similar.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Interpretation of BMD changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In treated patients who are adherent to therapy, stability or an increase in BMD is an acceptable response. A post hoc analysis of data in 2984 women from the Fracture Intervention Trial of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/10/24743?source=see_link\">",
"     alendronate",
"    </a>",
"    showed that the greatest fracture reduction occurred in those who gained BMD, although those with stable BMD still had fewer fractures than those who lost BMD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/25\">",
"     25",
"    </a>",
"    ]. Loss of BMD more than the LSC is cause for clinical concern and may be associated with poor adherence to therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/26-29\">",
"     26-29",
"    </a>",
"    ], or previously unrecognized contributing factors that require additional intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link&amp;anchor=H31#H31\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\", section on 'Monitoring the response to therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Vertebral fracture assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertebral fractures are a strong predictor of future fractures of all types [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/31\">",
"     31",
"    </a>",
"    ]. Vertebral fractures are the most common type of fragility fracture, yet about two-thirds of vertebral fractures are not clinically detected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/32\">",
"     32",
"    </a>",
"    ]. Vertebral fracture assessment (VFA) by DXA is a method of visualizing the spine to detect vertebral fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/33\">",
"     33",
"    </a>",
"    ]. This can be done at the time of BMD testing, at greater patient convenience, less cost, and lower radiation exposure than conventional radiography of the spine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    VFA compares favorably with spine radiographs in detecting moderate and severe vertebral fractures (VFs), but it does not perform as well for diagnosing mild VFs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. In one study of women age 65 years and older, the sensitivity and specificity of VFA for detecting moderate and severe VFs was 87 to 93 percent and 93 to 95 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Identification of previously undetected vertebral fractures may change the diagnostic classification, fracture risk profile, and clinical management. The ISCD has published guidelines addressing the potential indications for VFA (",
"    <a class=\"graphic graphic_table graphicRef82411 \" href=\"mobipreview.htm?28/47/29436\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     NOMENCLATURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;DXA, not DEXA, is the preferred acronym for dual-energy x-ray absorptiometry. T-score should be used with no italics, not T score, t-score or t score. Similarly, Z-score with no italics, not Z score, z-score or z score should be used. These should be expressed to one decimal digit, eg, -2.3, not -2 or -2.31. BMD should be expressed to three decimal digits, eg, 0.946",
"    <span class=\"nowrap\">",
"     g/cm2",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42583/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/6/23650?source=see_link\">",
"       \"Patient information: Bone density testing (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/58/35746?source=see_link\">",
"       \"Patient information: Osteoporosis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/12/36034?source=see_link\">",
"       \"Patient information: Calcium and vitamin D for bone health (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/29/1491?source=see_link\">",
"       \"Patient information: Bone density testing (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/49/25366?source=see_link\">",
"       \"Patient information: Osteoporosis prevention and treatment (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/60/23491?source=see_link\">",
"       \"Patient information: Calcium and vitamin D for bone health (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;DXA is the best available clinical tool for the diagnosis of osteoporosis and monitoring changes in BMD over time.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The World Health Organization (WHO) has established a classification of BMD according to T-score that is the worldwide standard for diagnosis of osteoporosis (",
"      <a class=\"graphic graphic_table graphicRef53999 \" href=\"mobipreview.htm?6/54/7019\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis of osteoporosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The WHO recommends that the diagnosis of osteoporosis be made using measurements of DXA at the femoral neck. However, the National Osteoporosis Foundation (NOF) and the International Society for Clinical Densitometry (ISCD) suggest that the diagnosis of osteoporosis be made using the lowest T-score measured by DXA of the lumbar spine (L1-L4), total proximal femur, femoral neck, or one-third radius. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Skeletal site selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The WHO recommends the use of the NHANES III Caucasian young-adult reference database for calculation of T-score at the hip, using a female database for women and for men. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Reference databases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The WHO criteria should be used for diagnostic classification in postmenopausal women, perimenopausal women, and for men age 50 years and older. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis of osteoporosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The WHO criteria should not be used for premenopausal women, men under age 50 years, or children. In these populations, Z-scores rather than T-scores should be used. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis of osteoporosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The same DXA instrument should be used for serial BMD testing whenever possible. It is not possible to quantify BMD changes on measurements made on different instruments unless a cross-calibration study has been done. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Serial BMD testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Identification of previously undetected vertebral fractures may change the diagnostic classification, fracture risk assessment, and clinical management. Vertebral fracture assessment (VFA) by DXA is a method of visualizing the spine to detect vertebral fractures. VFA compares favorably with spine radiographs in detecting moderate and severe vertebral fractures (VFs), but it does not perform as well for diagnosing mild VFs. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Vertebral fracture assessment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation, 2010. file://www.nof.org/sites/default/files/pdfs/NOF_ClinicianGuide2009_v7.pdf (Accessed on June 14, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/2\">",
"      NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/3\">",
"      Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007; 22:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/4\">",
"      Riggs BL, Melton LJ 3rd. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995; 17:505S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/5\">",
"      Cooper C, Atkinson EJ, Jacobsen SJ, et al. Population-based study of survival after osteoporotic fractures. Am J Epidemiol 1993; 137:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/6\">",
"      Watts NB. Bone quality: getting closer to a definition. J Bone Miner Res 2002; 17:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/7\">",
"      Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/8\">",
"      Baim S, Binkley N, Bilezikian JP, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 2008; 11:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/9\">",
"      El Maghraoui A, Roux C. DXA scanning in clinical practice. QJM 2008; 101:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/10\">",
"      Lotz JC, Cheal EJ, Hayes WC. Fracture prediction for the proximal femur using finite element models: Part I--Linear analysis. J Biomech Eng 1991; 113:353.",
"     </a>",
"    </li>",
"    <li>",
"     Kanis, JA, on behalf of the World Health Organization Scientific Group (2007). Assessment of osteoporosis at the primary health-care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. 2007: Printed by the University of Sheffield. file://www.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf (Accessed on November 02, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/12\">",
"      Cranney A, Guyatt G, Griffith L, et al. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 2002; 23:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/13\">",
"      Wasnich RD, Miller PD. Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab 2000; 85:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/14\">",
"      Mazess R, Chesnut CH 3rd, McClung M, Genant H. Enhanced precision with dual-energy X-ray absorptiometry. Calcif Tissue Int 1992; 51:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/15\">",
"      Njeh CF, Fuerst T, Hans D, et al. Radiation exposure in bone mineral density assessment. Appl Radiat Isot 1999; 50:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/16\">",
"      Shepherd JA, Lu Y, Wilson K, et al. Cross-calibration and minimum precision standards for dual-energy X-ray absorptiometry: the 2005 ISCD Official Positions. J Clin Densitom 2006; 9:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/17\">",
"      Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone 2008; 42:467.",
"     </a>",
"    </li>",
"    <li>",
"     The International Society for Clinical Densitometry. Official positions. www.iscd.org/Visitors/positions/OfficialPositionsText.cfm (Accessed on June 01, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/19\">",
"      Kanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 2001; 12:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/20\">",
"      Melton, LJ III, Chrischilles, EA, Cooper, C, et al. How many women have osteoporosis? J Bone Miner Res 1992; 7:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/21\">",
"      Writing Group for the ISCD Position Development Conference. Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom 2004; 7:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/22\">",
"      Baim S, Leonard MB, Bianchi ML, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 2008; 11:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/23\">",
"      Lenchik L, Kiebzak GM, Blunt BA, International Society for Clinical Densitometry Position Development Panel and Scientific Advisory Committee. What is the role of serial bone mineral density measurements in patient management? J Clin Densitom 2002; 5 Suppl:S29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/24\">",
"      Binkley N, Kiebzak GM, Lewiecki EM, et al. Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. J Bone Miner Res 2005; 20:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/25\">",
"      Hochberg MC, Ross PD, Black D, et al. Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum 1999; 42:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/26\">",
"      Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 1997; 102:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/27\">",
"      Ravnikar VA. Compliance with hormone therapy. Am J Obstet Gynecol 1987; 156:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/28\">",
"      McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004; 48:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/29\">",
"      Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 2004; 15:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/30\">",
"      Lewiecki EM. Nonresponders to osteoporosis therapy. J Clin Densitom 2003; 6:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/31\">",
"      Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/32\">",
"      Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ 3rd. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992; 7:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/33\">",
"      Ferrar L, Jiang G, Adams J, Eastell R. Identification of vertebral fractures: an update. Osteoporos Int 2005; 16:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/34\">",
"      Lewiecki EM, Laster AJ. Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. J Clin Endocrinol Metab 2006; 91:4215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/35\">",
"      Schousboe JT, Debold CR. Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos Int 2006; 17:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/36\">",
"      Hospers IC, van der Laan JG, Zeebregts CJ, et al. Vertebral fracture assessment in supine position: comparison by using conventional semiquantitative radiography and visual radiography. Radiology 2009; 251:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42583/abstract/37\">",
"      Writing Group for the ISCD Position Development Conference. Nomenclature and decimal places in bone densitometry. J Clin Densitom 2004; 7:45.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2056 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-67CE5B8581-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42583=[""].join("\n");
var outline_f41_37_42583=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BONE QUALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BMD testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DXA TECHNOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL APPLICATIONS OF DXA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Skeletal site selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Reference databases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Diagnosis of osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Premenopausal women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Men",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Serial BMD testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Precision assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Time interval for repeating DXA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Skeletal site to monitor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Validity of comparisons",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Interpretation of BMD changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Vertebral fracture assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      NOMENCLATURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/2056\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/2056|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/60/29646\" title=\"figure 1\">",
"      Typical DXA system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/2056|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/48/33547\" title=\"table 1\">",
"      Indications bone density",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/54/7019\" title=\"table 2\">",
"      Bone mineral density T-score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/47/29436\" title=\"table 3\">",
"      Indications for VFA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/55/11128?source=related_link\">",
"      Diagnosis and evaluation of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/25/6553?source=related_link\">",
"      Epidemiology and etiology of premenopausal osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=related_link\">",
"      Osteoporotic fracture risk assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/29/1491?source=related_link\">",
"      Patient information: Bone density testing (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/6/23650?source=related_link\">",
"      Patient information: Bone density testing (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/60/23491?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/12/36034?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/58/35746?source=related_link\">",
"      Patient information: Osteoporosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/49/25366?source=related_link\">",
"      Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/28/40393?source=related_link\">",
"      Screening for osteoporosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_37_42584="Management of tissue wasting in patients with HIV infection";
var content_f41_37_42584=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of tissue wasting in patients with HIV infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42584/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42584/contributors\">",
"     Steven K Grinspoon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42584/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42584/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42584/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42584/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/37/42584/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight loss and tissue wasting are common in patients with human immunodeficiency virus (HIV) infection, particularly in the later stages of the disease. The causes are multiple, and include hypogonadism, malnutrition, anorexia, infection, and perhaps an HIV-induced hypermetabolic state. However, the incidence of wasting has declined since the introduction of potent antiretroviral treatments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/50/22312?source=see_link\">",
"     \"Pituitary and adrenal gland dysfunction in HIV-infected patients\"",
"    </a>",
"    .) The American Gastroenterological Association (AGA) technical",
"    <span class=\"nowrap\">",
"     review/guideline",
"    </span>",
"    for malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with HIV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/2\">",
"     2",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     IMPLICATIONS OF WEIGHT LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involuntary weight loss is associated with disease progression and death, even when access to highly active antiretroviral therapy (HAART) is available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/3\">",
"     3",
"    </a>",
"    ]. In a cohort of 881 HIV-infected patients who were followed in the Nutrition for Health Living Cohort, weight loss was associated with lower CD4+ T-cell counts and was an independent predictor of mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of wasting in HIV-infected patients is not well understood. Resting energy expenditure is often increased and a hypermetabolic state has been proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]; however, it is difficult to relate this change to weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/7\">",
"     7",
"    </a>",
"    ]. In two studies of 36 HIV-infected men, for example, resting energy expenditure was modestly increased but total energy expenditure was similar to that in normal men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Weight loss in these patients was primarily due to decreased energy intake; during periods of rapid weight loss, energy expenditure fell below normal due to reduced physical activity but was still greater than energy intake.",
"   </p>",
"   <p>",
"    Rapid weight loss is usually due to a secondary infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/8,10\">",
"     8,10",
"    </a>",
"    ], while gradual weight loss is often a reflection of gastrointestinal disease with diarrhea and less marked reductions in energy intake [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/8,11\">",
"     8,11",
"    </a>",
"    ]. There is, however, no good explanation for the failure of energy expenditure to fall when caloric intake decreases during gradual weight loss, as it does in patients without HIV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both lean body mass and fat are lost; muscle loss is more prominent, at least in men, and is a major cause of weakness in those who have lost more than 10 percent of their body weight. Loss of muscle mass may be due to an inflammatory myopathy. However, in one series, only 3 of 30 HIV-infected patients with muscle wasting had a specific inflammatory myopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/13\">",
"     13",
"    </a>",
"    ]. By contrast, fat mass is lost disproportionately in the early stages of wasting in HIV-infected women; muscle loss predominates in the later stages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One endocrine cause of the weight loss may be hypogonadism, which is not uncommon and seen in up to 50 percent of men and women with advanced HIV disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/50/22312?source=see_link\">",
"     \"Pituitary and adrenal gland dysfunction in HIV-infected patients\"",
"    </a>",
"    .) Moreover, hypogonadism also occurs in up to 20 percent of HIV-infected men receiving highly active antiretroviral therapy (HAART) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/16\">",
"     16",
"    </a>",
"    ]. There is a direct correlation between the reduction in serum testosterone concentrations and tissue wasting in both men and women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/14,17\">",
"     14,17",
"    </a>",
"    ]. Growth hormone (GH) deficiency is not responsible for the weight loss in such patients, but resistance to the action of GH, as evidenced by low serum insulin-like growth factor-I (IGF-I) concentrations, occurs when there is at least a 10 percent fall in body weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/18\">",
"     18",
"    </a>",
"    ]. The modestly raised serum cortisol concentrations that occur in some patients are not correlated with changes in weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/19\">",
"     19",
"    </a>",
"    ]. A decrease in appetite might be related to a raised serum concentration of cholecystokinin (specifically CCK-8 sulfate) or tumor necrosis factor (TNF)-alpha [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lactic acidosis can occur in patients treated with highly active antiretroviral therapy (HAART), particularly with treatment with the nucleoside reverse transcriptase inhibitors",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/45/43734?source=see_link\">",
"     stavudine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/21,22\">",
"     21,22",
"    </a>",
"    ], and is associated with fatigue, anorexia, muscle aches, and occasionally severe weight loss. These medications are no longer considered first line agents due to these associated drug toxicities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/26/39332?source=see_link&amp;anchor=H8#H8\">",
"     \"Electrolyte disturbances with HIV infection\", section on 'Lactic acidosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36234?source=see_link\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\"",
"    </a>",
"    .) Lactic acidosis is not a common cause of muscle wasting, in patients who are losing weight on HAART, but should be considered in patients with weight loss, anorexia, and muscle aches.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH TO THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initiation of antiretroviral therapy with subsequent viral suppression among therapy-naive patients increases weight (+2.6 kg) and lean body mass (+1.0 kg) over a relatively short-duration of 16 weeks, with greater increases seen among those with severe baseline immunodeficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/23\">",
"     23",
"    </a>",
"    ]. Increased dietary protein intake or simply increased caloric intake is reasonably effective for increasing total body protein or fat-free mass when there is known weight loss; this dietary approach should be encouraged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. However, caloric supplements in patients with a stable weight do not affect further changes in body weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/26\">",
"     26",
"    </a>",
"    ]. In addition, adequate",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/8/24707?source=see_link\">",
"     cysteine",
"    </a>",
"    intake may help [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Otherwise, treatment for tissue wasting in HIV infection consists of increased exercise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/28,29\">",
"     28,29",
"    </a>",
"    ], the administration of hormones or hormone-like drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/30\">",
"     30",
"    </a>",
"    ], or both. Hormonal therapy should be based upon documentation of hormonal deficiencies rather than used empirically.",
"   </p>",
"   <p>",
"    When possible, the primary therapy of HIV wasting is treatment of the underlying HIV infection with highly active antiretroviral therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36234?source=see_link\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/26/36265?source=see_link\">",
"     \"Modifying HIV antiretroviral therapy regimens\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a 16-week randomized, placebo-controlled trial in 61 men with AIDS, weight loss, and low serum testosterone concentrations, vigorous resistance exercise resulted in a significant increase in body weight (P=0.02) and muscle strength (P&lt;0.05) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/28\">",
"     28",
"    </a>",
"    ]. In contrast, in a similar 12-week trial of 54 men with AIDS and weight loss who were eugonadal, exercise alone did not lead to an increase in either body weight or muscle strength, although there was an increase in muscle mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/29\">",
"     29",
"    </a>",
"    ]. Both studies also examined the effects of testosterone (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Steroid hormones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Steroid hormones are often used to treat HIV-induced tissue wasting. These include testosterone,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/55/33653?source=see_link\">",
"     megestrol acetate",
"    </a>",
"    , nandrolone and dehydroepiandrosterone (DHEA).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Testosterone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypogonadism is common in men with AIDS wasting. A serum testosterone level should be obtained in the morning in such patients to establish the diagnosis of hypogonadism. In borderline cases, results should be confirmed and use of a free (bioavailable) testosterone level should be considered. Other causes of hypogonadism should also be considered in such patients. Testosterone therapy should be offered to men with documented hypogonadism. The diagnosis and treatment of hypogonadism are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=see_link&amp;anchor=H7#H7\">",
"     \"Clinical features and diagnosis of male hypogonadism\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1545?source=see_link\">",
"     \"Testosterone treatment of male hypogonadism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effects of testosterone in patients with HIV infection have varied, as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a trial of 51 men with low serum testosterone concentrations, intramuscular testosterone (300 mg testosterone enanthate every three weeks for six months) led to a significant increase in lean body mass and quality of life [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among HIV-infected men with weight loss and low serum testosterone, the combination of testosterone enanthate (100",
"      <span class=\"nowrap\">",
"       mg/week",
"      </span>",
"      intramuscularly) and exercise was no more effective than either one alone in achieving significant weight gain, increase in muscle strength and mass, and increase in lean body mass [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast to the above findings, two randomized trials comparing transdermal testosterone to placebo in HIV-infected patients with low serum testosterone did not demonstrate a benefit in lean body mass or weight gain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/32,33\">",
"       32,33",
"      </a>",
"      ] or in the quality in life [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Testosterone therapy in hypogonadal patients with AIDS also may be associated with lower depression scores [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although not recommended, it has been suggested that testosterone therapy can be effective in the absence of hypogonadism. Potential benefits include decreased fatigue, improvement in libido and depression, and increased bone mineral density [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/35-37\">",
"     35-37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In HIV-infected women with wasting, there may be significant shunting of adrenal steroid metabolism away from androgenic pathways and toward cortisol production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/38\">",
"     38",
"    </a>",
"    ]. In such patients, transdermal testosterone has been associated with weight gain and an increase in muscle mass and strength [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Oxandrolone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anabolic steroids other than testosterone, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/28/39364?source=see_link\">",
"     oxandrolone",
"    </a>",
"    , also may be beneficial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. In one study, 22 eugonadal HIV-infected men with weight loss were randomly assigned to receive supervised progressive resistance exercise with physiologic intramuscular testosterone replacement with or without additional oxandrolone therapy (20",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    orally) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/41\">",
"     41",
"    </a>",
"    ]. Those who received additional oxandrolone had a significant increase in weight, strength, and lean body mass compared to the",
"    <span class=\"nowrap\">",
"     exercise/testosterone",
"    </span>",
"    arm alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Nandrolone",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of nandrolone on lean body mass has been studied in HIV-infected patients with and without wasting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/44-48\">",
"     44-48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One double-blind, randomized, 12-week trial compared placebo (n=22) to nandrolone (n=43) in HIV-infected men who had a history of 5 to 15 percent weight loss; a comparator group (n=21) received open label",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/54/12137?source=see_link\">",
"     recombinant human growth hormone",
"    </a>",
"    (rhGH) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/48\">",
"     48",
"    </a>",
"    ]. Nandrolone was associated with a greater increase in lean body mass (LBM) by dual-energy x-ray absorptiometry scan than placebo; however the change in LBM was not significantly different from rhGH.",
"   </p>",
"   <p>",
"    The effect of nandrolone on weight and lean body mass in HIV-infected women was assessed in a blinded randomized trial of 38 patients with a history of weight loss or a body mass index less than 20",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/47\">",
"     47",
"    </a>",
"    ]. The women were randomly assigned to 100 mg of intramuscular nandrolone versus placebo for 12 weeks followed by a 12 week open label treatment phase for all subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/47\">",
"     47",
"    </a>",
"    ]. Nandrolone therapy was associated with significant increases in weight and lean body mass (4.6 kg and 3.5 kg, respectively), no hepatotoxicity, and more virilizing effects. The study size was too small to adequately assess the safety of this medication in women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Megestrol acetate",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/55/33653?source=see_link\">",
"     Megestrol acetate",
"    </a>",
"    (Megace) is used less frequently because it is less effective and more expensive. When given orally in a dose of 400 to 800",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    it can increase both appetite and weight (energy intake 474",
"    <span class=\"nowrap\">",
"     kcal/day",
"    </span>",
"    and weight gain 4.3 kg, respectively, compared with placebo at 12 weeks in a controlled trial) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/49\">",
"     49",
"    </a>",
"    ]. However, the increase in weight is mainly fat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/55/33653?source=see_link\">",
"     Megestrol acetate",
"    </a>",
"    also has some glucocorticoid and possibly antiglucocorticoid properties, and therefore can inhibit pituitary-adrenal function. With chronic administration, this agent suppresses both the hypothalamic-pituitary-adrenal (HPA) and the hypothalamic-pituitary-gonadal (HPG) axes. As a result, transient adrenal and testosterone deficiency can occur during or after its use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/51,52\">",
"     51,52",
"    </a>",
"    ] and lead to significant hypogonadism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/50/3880?source=see_link\">",
"     \"Causes of secondary and tertiary adrenal insufficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/55/33653?source=see_link\">",
"     megestrol acetate",
"    </a>",
"    can lead to iatrogenic Cushing's syndrome and diabetes mellitus. Therefore, the sudden discontinuation of chronic therapy can precipitate adrenal insufficiency in some patients; thus, doses should be tapered gradually.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Dehydroepiandrosterone (DHEA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;DHEA has been proposed as a therapy for tissue wasting because serum concentrations of both DHEA and DHEA sulfate are low in patients with HIV infection, particularly those patients with more progressive disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. However, there are no data from controlled trials to support the use of DHEA for the prevention or treatment of tissue wasting, although it may reduce fatigue and improve mood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Oxymetholone",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oral anabolic steroid",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/39/10868?source=see_link\">",
"     oxymetholone",
"    </a>",
"    is associated with significant liver toxicity in more than one-fourth of patients and is not recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Growth hormone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several peptide hormones are being tried in an attempt to reverse the tissue wasting in HIV disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/57-59\">",
"     57-59",
"    </a>",
"    ]. The best studied is recombinant human GH. GH secretion is rarely deficient in HIV-infected patients, but the rationale for its administration is that HIV-infected patients have resistance to GH action, and overcoming that resistance may reverse tissue wasting and increase muscle mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/17\">",
"     17",
"    </a>",
"    ]. GH has been given both with and without simultaneous administration of IGF-I.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one randomized trial of 142 patients with HIV-induced wasting, GH (0.34 mg twice daily subcutaneously) and IGF-I had no effect on weight, fat-free mass, muscle strength, or quality of life [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/60\">",
"       60",
"      </a>",
"      ]. Adverse effects such as headache, edema, and asthenia were significantly more common in the treated patients.",
"     </li>",
"     <li>",
"      In another trial of 60 patients, only those who received both peptides had a significant increase in lean body mass (mean 3.2 kg). However, combination therapy was accompanied by edema, arthralgia, or myalgia. The authors recommended against the use of this therapy because of the modest weight gain and uncertain overall benefit.",
"     </li>",
"     <li>",
"      In contrast, GH (0.1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) improved lean body mass in a randomized, placebo-controlled study of 178 patients with AIDS wasting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/57\">",
"       57",
"      </a>",
"      ]. Significant side effects, including swelling and joint pain, occurred in the GH-treated patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, treatment of HIV-related wasting with growth factors (GH, IGF-I, or both) was not effective in all studies and was associated with significant side effects at high doses. There may also be differences in response to growth hormone related to gender and race. In one study of HIV-infected males (n=139) and females (n=25), HIV-infected women demonstrated much better responses to growth hormone releasing hormone than men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/61\">",
"     61",
"    </a>",
"    ]. Furthermore, responses were also more significant in non-Caucasian than Caucasian male HIV-infected subjects.",
"   </p>",
"   <p>",
"    The therapy is expensive: a 12-week course at the GH doses used in the one effective study currently would cost US$12,000 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/58\">",
"     58",
"    </a>",
"    ]. There are no data on cost effectiveness or on changes in survival, nor has GH or IGF-I therapy been compared with other therapies. Furthermore, the proper dose and indications for therapy remain undefined. Although in vitro data indicate that GH may increase viral replication in peripheral blood white cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/62\">",
"     62",
"    </a>",
"    ], GH may also increase thymic mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/63\">",
"     63",
"    </a>",
"    ], and further studies on the effects of GH on immune function are needed.",
"   </p>",
"   <p>",
"    Despite these limitations, the United States Food and Drug Administration (FDA) has approved therapy with GH for patients with HIV-related weight loss under an expanded access program. GH should be used judiciously and only in HIV-infected patients with significant wasting in whom other therapies have proven ineffective.",
"   </p>",
"   <p>",
"    Some studies suggest that GH levels may be low in HIV-infected patients with abdominal obesity and fat redistribution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/64,65\">",
"     64,65",
"    </a>",
"    ], and some reports suggest that GH in high doses (6",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    may improve or reverse the increased abdominal fat deposits in these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. A randomized trial of GH 4",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    showed significant effects on visceral fat, but initial exacerbations of insulin resistance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/68\">",
"     68",
"    </a>",
"    ]. Even lower, but still supraphysiologic doses of 3",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    proved effective in reducing abdominal fat in a small pilot study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/69\">",
"     69",
"    </a>",
"    ]. However, controlled trials are needed to determine if physiologic GH can improve fat distribution in HIV-infected patients. A twelve-week trial in 29 men with lipodystrophy found that compared with placebo, patients treated with growth hormone releasing hormone (GHRH) showed increased lean mass, reduced truncal and visceral fat, and improved subjective ratings of lipodystrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/51/23352?source=see_link&amp;anchor=H25#H25\">",
"     \"Lipodystrophic syndromes\", section on 'Lipodystrophy associated with HIV therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Other peptides",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in animals suggest that human chorionic gonadotropin (hCG) or human stem-cell factor (also called c-kit ligand) can prevent wasting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. In one report, homozygous HIV-1 transgenic mice developed scaly skin lesions, growth failure, and died; hCG prevented death, led to normal growth, improved the skin lesions, and reduced HIV RNA expression in skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/72\">",
"     72",
"    </a>",
"    ]. Studies are needed to determine the efficacy of hCG in humans.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Dronabinol",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/49/30485?source=see_link\">",
"     Dronabinol",
"    </a>",
"    is a cannabinol derivative approved for use in increasing appetite in patients with AIDS-related anorexia and weight loss. The usual dose is 2.5 mg twice daily, which can be increased to 5 mg twice daily. Long-term therapy (12 months) in 94 patients led to a significant increase in appetite but no change in weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/73\">",
"     73",
"    </a>",
"    ]. Further, dronabinol can cause side effects such as confusion, emotional lability, or hallucinations.",
"   </p>",
"   <p>",
"    The short-term use of marijuana cigarettes was shown to be safe with respect to immune function in HIV-infected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/74\">",
"     74",
"    </a>",
"    ]. However, effects on weight and body composition were not assessed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Thalidomide",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a small controlled trial of 28 patients with HIV-related wasting,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/62/29673?source=see_link\">",
"     thalidomide",
"    </a>",
"    (100 mg four times daily) resulted in a significant increase in weight after 12 weeks of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/75\">",
"     75",
"    </a>",
"    ]. In a double-blind, placebo-controlled study of 103 male patients with AIDS wasting, weight gain was seen over eight weeks but was associated with significant adverse effects including rash, fevers, and increased viral load [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/76\">",
"     76",
"    </a>",
"    ]. Thalidomide is now FDA approved only for the treatment of erythema nodosum leprosum, a complication of lepromatous leprosy. It also helps heal oral aphthous ulcers in patients with HIV infection, probably by inhibiting the production of TNF-alpha [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42584/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    GH should be reserved for those patients with severe wasting in whom other treatments have not proven efficacious. Exercise has also been shown to promote lean tissue among patients with wasting and should be considered alone or in combination with other treatment strategies for those who are capable of exercising.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21910164\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight loss and tissue wasting are common in patients with advanced AIDS, although the incidence of wasting has declined since the introduction of potent antiretroviral therapy. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Involuntary weight loss is associated with disease progression and death, even when access to potent antiretroviral medications is available. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Implications of weight loss'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rapid weight loss is usually due to a secondary infection, while gradual weight loss is often a reflection of gastrointestinal disease with diarrhea. Hypogonadism is a common endocrine cause of wasting in patients with advanced immunosuppression. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When possible, the primary therapy of HIV wasting is treatment of the underlying HIV infection with antiretroviral therapy. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'General approach to therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Exercise has also been shown to promote lean tissue in small studies of AIDS patients with wasting and should be considered alone or in combination with other treatment strategies for those who are capable of exercising. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Exercise'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypogonadism is common in men with AIDS wasting. A serum testosterone level should be obtained in the morning in such patients to establish the diagnosis of hypogonadism. In borderline cases, results should be confirmed and use of a free (bioavailable) testosterone level should be considered. Other causes of hypogonadism should also be considered in such patients. Testosterone therapy should be offered to men with documented hypogonadism. The diagnosis and treatment of hypogonadism are discussed in detail separately. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Steroid hormones'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features and diagnosis of male hypogonadism\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1545?source=see_link\">",
"       \"Testosterone treatment of male hypogonadism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other steroid hormones, including",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/55/33653?source=see_link\">",
"       megestrol acetate",
"      </a>",
"      , nandrolone, and dehydroepiandrosterone have been shown to be efficacious in small studies of tissue wasting, but megestrol acetate and oral anabolic steroids are associated with significant adverse effects (adrenal suppression with megestrol; hepatotoxicity with anabolic steroids) and should be used with caution, if at all. The data on dehydroepiandrosterone are not adequate to recommend its use in tissue wasting. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Steroid hormones'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Growth hormone secretion is rarely deficient in HIV-infected patients, but the rationale for its administration is that HIV-infected patients have resistance to growth hormone action, and overcoming that resistance may reverse tissue wasting and increase muscle mass. Growth hormone should be reserved for those patients with severe wasting in whom other treatments have not proven efficacious. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Growth hormone'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/1\">",
"      Dworkin MS, Williamson JM, Adult/Adolescent Spectrum of HIV Disease Project. AIDS wasting syndrome: trends, influence on opportunistic infections, and survival. J Acquir Immune Defic Syndr 2003; 33:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/2\">",
"      American Gastroenterological Association medical position statement: guidelines for the management of malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection. Gastroenterology 1996; 111:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/3\">",
"      Wanke CA, Silva M, Knox TA, et al. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 31:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/4\">",
"      Mangili A, Murman DH, Zampini AM, Wanke CA. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis 2006; 42:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/5\">",
"      Hommes MJ, Romijn JA, Endert E, Sauerwein HP. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 1991; 54:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/6\">",
"      Mulligan K, Grunfeld C, Hellerstein MK, et al. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993; 77:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/7\">",
"      Grunfeld C, Pang M, Shimizu L, et al. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992; 55:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/8\">",
"      Macallan DC, Noble C, Baldwin C, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995; 333:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/9\">",
"      Heijligenberg R, Romijn JA, Westerterp KR, et al. Total energy expenditure in human immunodeficiency virus-infected men and healthy controls. Metabolism 1997; 46:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/10\">",
"      Macallan DC, Noble C, Baldwin C, et al. Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr 1993; 58:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/11\">",
"      Grunfeld C. What causes wasting in AIDS? N Engl J Med 1995; 333:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/12\">",
"      Sellmeyer DE, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev 1996; 17:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/13\">",
"      Mir&oacute; O, Pedrol E, Cebri&aacute;n M, et al. Skeletal muscle studies in patients with HIV-related wasting syndrome. J Neurol Sci 1997; 150:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/14\">",
"      Grinspoon S, Corcoran C, Miller K, et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 1997; 82:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/15\">",
"      Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988; 84:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/16\">",
"      Rietschel P, Corcoran C, Stanley T, et al. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis 2000; 31:1240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/17\">",
"      Grinspoon S, Corcoran C, Lee K, et al. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab 1996; 81:4051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/18\">",
"      Frost RA, Fuhrer J, Steigbigel R, et al. Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clin Endocrinol (Oxf) 1996; 44:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/19\">",
"      Christeff N, Gherbi N, Mammes O, et al. Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology 1997; 22 Suppl 1:S11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/20\">",
"      Arnalich F, Martinez P, Hernanz A, et al. Altered concentrations of appetite regulators may contribute to the development and maintenance of HIV-associated wasting. AIDS 1997; 11:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/21\">",
"      Carr A, Miller J, Law M, Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 2000; 14:F25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/22\">",
"      Falc&oacute; V, Rodr&iacute;guez D, Ribera E, et al. Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis 2002; 34:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/23\">",
"      Shikuma CM, Zackin R, Sattler F, et al. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis 2004; 39:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/24\">",
"      Selberg O, S&uuml;ttmann U, Melzer A, et al. Effect of increased protein intake and nutritional status on whole-body protein metabolism of AIDS patients with weight loss. Metabolism 1995; 44:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/25\">",
"      Schwenk A, Steuck H, Kremer G. Oral supplements as adjunctive treatment to nutritional counseling in malnourished HIV-infected patients: randomized controlled trial. Clin Nutr 1999; 18:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/26\">",
"      Gibert CL, Wheeler DA, Collins G, et al. Randomized, controlled trial of caloric supplements in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr 1999; 22:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/27\">",
"      Dr&ouml;ge W, Holm E. Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB J 1997; 11:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/28\">",
"      Bhasin S, Storer TW, Javanbakht M, et al. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 2000; 283:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/29\">",
"      Grinspoon S, Corcoran C, Parlman K, et al. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 2000; 133:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/30\">",
"      Corcoran C, Grinspoon S. Treatments for wasting in patients with the acquired immunodeficiency syndrome. N Engl J Med 1999; 340:1740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/31\">",
"      Grinspoon S, Corcoran C, Askari H, et al. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998; 129:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/32\">",
"      Bhasin S, Storer TW, Asbel-Sethi N, et al. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 1998; 83:3155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/33\">",
"      Dobs AS, Cofrancesco J, Nolten WE, et al. The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection. Am J Med 1999; 107:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/34\">",
"      Grinspoon S, Corcoran C, Stanley T, et al. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab 2000; 85:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/35\">",
"      Rabkin JG, Wagner GJ, Rabkin R. Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. J Clin Psychopharmacol 1999; 19:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/36\">",
"      Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000; 57:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/37\">",
"      Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab 2001; 86:2020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/38\">",
"      Grinspoon S, Corcoran C, Stanley T, et al. Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome. J Clin Endocrinol Metab 2001; 86:4120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/39\">",
"      Miller K, Corcoran C, Armstrong C, et al. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab 1998; 83:2717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/40\">",
"      Dolan S, Wilkie S, Aliabadi N, et al. Effects of testosterone administration in human immunodeficiency virus-infected women with low weight: a randomized placebo-controlled study. Arch Intern Med 2004; 164:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/41\">",
"      Strawford A, Barbieri T, Van Loan M, et al. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA 1999; 281:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/42\">",
"      Berger JR, Pall L, Hall CD, et al. Oxandrolone in AIDS-wasting myopathy. AIDS 1996; 10:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/43\">",
"      Hengge UR, Baumann M, Maleba R, et al. Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection. Br J Nutr 1996; 75:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/44\">",
"      Sattler FR, Jaque SV, Schroeder ET, et al. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. J Clin Endocrinol Metab 1999; 84:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/45\">",
"      Gold J, High HA, Li Y, et al. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection. AIDS 1996; 10:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/46\">",
"      Strawford A, Barbieri T, Neese R, et al. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/47\">",
"      Mulligan K, Zackin R, Clark RA, et al. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. Arch Intern Med 2005; 165:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/48\">",
"      Storer TW, Woodhouse LJ, Sattler F, et al. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment. J Clin Endocrinol Metab 2005; 90:4474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/49\">",
"      Oster MH, Enders SR, Samuels SJ, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994; 121:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/50\">",
"      Strang P. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review). Anticancer Res 1997; 17:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/51\">",
"      Leinung MC, Liporace R, Miller CH. Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med 1995; 122:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/52\">",
"      Mann M, Koller E, Murgo A, et al. Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Arch Intern Med 1997; 157:1651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/53\">",
"      Mulder JW, Frissen PH, Krijnen P, et al. Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. J Infect Dis 1992; 165:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/54\">",
"      de la Torre B, von Krogh G, Svensson M, Holmberg V. Blood cortisol and dehydroepiandrosterone sulphate (DHEAS) levels and CD4 T cell counts in HIV infection. Clin Exp Rheumatol 1997; 15:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/55\">",
"      Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology 2000; 25:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/56\">",
"      Hengge UR, Stocks K, Wiehler H, et al. Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting. AIDS 2003; 17:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/57\">",
"      Schambelan M, Mulligan K, Grunfeld C, et al. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med 1996; 125:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/58\">",
"      Mantzoros CS, Moses AC. Whither recombinant human growth hormone? Ann Intern Med 1996; 125:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/59\">",
"      McNurlan MA, Garlick PJ, Steigbigel RT, et al. Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease. J Clin Invest 1997; 100:2125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/60\">",
"      Lee PD, Pivarnik JM, Bukar JG, et al. A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1996; 81:2968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/61\">",
"      Koutkia P, Eaton K, You SM, et al. Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution. AIDS 2006; 20:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/62\">",
"      Laurence J, Grimison B, Gonenne A. Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro. Blood 1992; 79:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/63\">",
"      Napolitano LA, Lo JC, Gotway MB, et al. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS 2002; 16:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/64\">",
"      Rietschel P, Hadigan C, Corcoran C, et al. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy. J Clin Endocrinol Metab 2001; 86:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/65\">",
"      Koutkia P, Meininger G, Canavan B, et al. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy. Am J Physiol Endocrinol Metab 2004; 286:E296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/66\">",
"      Wanke C, Gerrior J, Kantaros J, et al. Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV. AIDS 1999; 13:2099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/67\">",
"      Mauss S, Wolf E, Jaeger H. Reversal of protease inhibitor-related visceral abdominal fat accumulation with recombinant human growth hormone. Ann Intern Med 1999; 131:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/68\">",
"      Kotler DP, Muurahainen N, Grunfeld C, et al. Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients. J Acquir Immune Defic Syndr 2004; 35:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/69\">",
"      Lo JC, Mulligan K, Noor MA, et al. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab 2001; 86:3480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/70\">",
"      Koutkia P, Canavan B, Breu J, et al. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial. JAMA 2004; 292:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/71\">",
"      De SK, Wohlenberg CR, Marinos NJ, et al. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice. J Clin Invest 1997; 99:1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/72\">",
"      Miles SA, Lee K, Hutlin L, et al. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias. Blood 1991; 78:3200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/73\">",
"      Beal JE, Olson R, Lefkowitz L, et al. Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage 1997; 14:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/74\">",
"      Abrams DI, Hilton JF, Leiser RJ, et al. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 2003; 139:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/75\">",
"      Reyes-Ter&aacute;n G, Sierra-Madero JG, Mart&iacute;nez del Cerro V, et al. Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. AIDS 1996; 10:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/76\">",
"      Kaplan G, Thomas S, Fierer DS, et al. Thalidomide for the treatment of AIDS-associated wasting. AIDS Res Hum Retroviruses 2000; 16:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/77\">",
"      Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997; 336:1487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42584/abstract/78\">",
"      Birnkrant D. Thalidomide for aphthous ulcers in HIV infection. N Engl J Med 1997; 337:1086.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3727 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-652B83C886-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42584=[""].join("\n");
var outline_f41_37_42584=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21910164\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      IMPLICATIONS OF WEIGHT LOSS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      GENERAL APPROACH TO THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Steroid hormones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Testosterone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Oxandrolone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Nandrolone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Megestrol acetate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Dehydroepiandrosterone (DHEA)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Oxymetholone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Growth hormone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Other peptides",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Dronabinol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Thalidomide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21910164\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/50/3880?source=related_link\">",
"      Causes of secondary and tertiary adrenal insufficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12824?source=related_link\">",
"      Clinical features and diagnosis of male hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/26/39332?source=related_link\">",
"      Electrolyte disturbances with HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/51/23352?source=related_link\">",
"      Lipodystrophic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/26/36265?source=related_link\">",
"      Modifying HIV antiretroviral therapy regimens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/50/22312?source=related_link\">",
"      Pituitary and adrenal gland dysfunction in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36234?source=related_link\">",
"      Selecting antiretroviral regimens for the treatment naive HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1545?source=related_link\">",
"      Testosterone treatment of male hypogonadism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_37_42585="Prenatal diagnosis of the lethal skeletal dysplasias";
var content_f41_37_42585=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prenatal diagnosis of the lethal skeletal dysplasias",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42585/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42585/contributors\">",
"     Phyllis Glanc, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42585/contributors\">",
"     David Chitayat, MD, FABMG, FACMG, FCCMG, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42585/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42585/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42585/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/37/42585/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/37/42585/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/37/42585/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H2348162\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skeletal dysplasias are a large, heterogeneous group of conditions involving the formation and growth of bone. Some skeletal dysplasias are associated with abnormalities in other organ systems. These disorders begin to manifest in the early stages of fetal development. They can be due to extrinsic causes (eg, teratogen exposure, maternal autoimmune disorders, etc) or intrinsic causes (single gene disorders with autosomal dominant, recessive, or X-linked modes of inheritance; imprinting errors; chromosome abnormalities) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/1\">",
"     1",
"    </a>",
"    ]. In view of the large number of skeletal dysplasias (over 456 known types), a classification system was created that categorizes genetic bone disorders into 40 major groups by their cardinal features (eg, radiological findings, molecular etiology, inheritance) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prenatal diagnosis is based primarily upon fetal ultrasound findings, but magnetic resonance imaging (MRI), computed tomography (CT), radiography, and in some cases, molecular analysis, may be used to support the presumptive diagnosis. Skeletal dysplasias can usually be identified by prenatal ultrasound examination because most of the skeleton begins to ossify early in development (the clavicle, mandible, ileum, scapula, and long bones ossify by 12 weeks of gestation; the metacarpals and metatarsals are ossified by 12 to 16 weeks; the talus and calcaneus ossify at weeks 22 to 24; but the carpal bones ossify after birth; epiphyseal ossification centers are seen on radiographs at approximately 20 weeks of gestation) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lethal group of skeletal dysplasias typically have an earlier onset with more severe phenotypic features than the non-lethal group, thus lethal skeletal dysplasia are potentially more amenable to early diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/5\">",
"     5",
"    </a>",
"    ]. Diagnostic accuracy is critical, as it will significantly affect parental counseling and decision making regarding continuation of the current pregnancy, as well as their options for prenatal diagnosis in their future pregnancies. In retrospective studies, experienced ultrasonographers made accurate prenatal diagnosis of lethal skeletal dysplasias in 81 to 100 percent of cases versus 31 to 78 percent of all cases of skeletal dysplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. The most challenging diagnoses are the skeletal dysplasia with variable phenotypic expression, which are not always lethal.",
"   </p>",
"   <p>",
"    After birth, postnatal radiographs, autopsy (in lethal cases), and molecular testing are crucial for making an accurate diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/3,9,10\">",
"     3,9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348169\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although each type of skeletal dysplasia is rare, the overall birth prevalence of skeletal dysplasias is estimated to be 2.4 per 10,000 births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The prevalence during pregnancy appears to be slightly higher at 7.5 per 10,000 ultrasound screened pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of lethal skeletal dysplasias ranges from 0.95 to 1.5 per 10,000 live births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/11,12,14\">",
"     11,12,14",
"    </a>",
"    ]. The three most common lethal skeletal dysplasias are thanatophoric dysplasia (TD, 29 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/15\">",
"     15",
"    </a>",
"    ], osteogenesis imperfect Type 2 (14 percent), and achondrogenesis (9 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/16\">",
"     16",
"    </a>",
"    ], which account for 40 to 60 percent of all lethal skeletal dysplasias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/6,8,12,17\">",
"     6,8,12,17",
"    </a>",
"    ]. Chondroectodermal dysplasia, campomelic dysplasia, and Jeune asphyxiating thoracic dysplasia are also among the more common lethal skeletal dysplasias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/7\">",
"     7",
"    </a>",
"    ]. These figures from specific tertiary centers reflect the rate of consanguinity and the specific ethnic background of the population served by the tertiary center.",
"   </p>",
"   <p>",
"    The overall frequency of perinatal deaths due to skeletal dysplasias is approximately 9 per 1000 births, with 23 percent stillborn and an additional 32 percent who do not survive beyond the first week of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/12,18\">",
"     12,18",
"    </a>",
"    ]. Overall, skeletal dysplasias account for about 5 percent of genetic disorders identified in the newborn period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348183\">",
"    <span class=\"h1\">",
"     OVERVIEW OF PRENATAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal skeletal dysplasias may be suspected because of qualitative bony abnormalities observed during a fetal anatomic survey or because the femur is found to be short for gestational age. In some cases, the initial ultrasound is performed because of a family history of skeletal dysplasia.",
"   </p>",
"   <p>",
"    Prenatal screening and diagnosis are primarily performed in the second trimester, but late first trimester fetal structural assessment is becoming more common with advances in transvaginal ultrasound imaging and the widespread use of first trimester screening for Down syndrome. Increased nuchal translucency can be associated with skeletal dysplasia; when this association is present, approximately 85 percent of cases are lethal skeletal dysplasias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/5,20\">",
"     5,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A comprehensive assessment of the fetal skeleton is necessary to determine which bones are affected and the type and severity of the abnormalities. The presence of associated abnormalities in other systems also needs to be assessed. The composite findings may or may not point to a specific skeletal dysplasia. Over the last decade, the accuracy of prenatal ultrasound for diagnosis of skeletal dysplasia has improved significantly: 68 percent for correct prenatal diagnosis and 31 percent for partially correct diagnosis, with 0.07 percent false positives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/6-9,21-23\">",
"     6-9,21-23",
"    </a>",
"    ]. A family history of consanguinity, a sibling or a parent affected with a skeletal dysplasia, or a prior affected fetus can help in making a specific diagnosis. However, the low incidence, phenotypic variability, overlapping features, and lack of family history in the majority of cases make a specific diagnosis, and thus prognostic counselling, difficult.",
"   </p>",
"   <p>",
"    Invasive procedures to obtain fetal cells for specific molecular tests can confirm the diagnosis in some cases.",
"   </p>",
"   <p>",
"    When a specific skeletal dysplasia cannot be identified, the goal is to determine whether the dysplasia is lethal or nonlethal. Diagnostic accuracy is critical, as the patient may choose to interrupt the pregnancy or avoid surgical delivery if the skeletal dysplasia is lethal or associated with morbidity and quality of life that are unacceptable to the parents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348190\">",
"    <span class=\"h1\">",
"     ULTRASOUND EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ultrasound evaluation of the bones includes their presence or absence, length, shape (curvature), and whether there are any fractures. These variables can be well visualized at &ge;14 weeks of gestation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33599731\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fetal femur is generally the only long bone routinely measured at the second-trimester ultrasound evaluation, although many scanning guidelines recommend the systematic documentation of the presence of all extremities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348199\">",
"    <span class=\"h3\">",
"     Short femur",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ossified portion of the femur is measured from the major trochanter to the distal end of the femoral shaft; the distal and proximal epiphyses are not included in the measurement (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50944 \" href=\"mobipreview.htm?32/16/33027\">",
"     image 1",
"    </a>",
"    ). Several longitudinal measurements should be obtained and the longest is recorded. Long bones have a primary ossification center in the diaphysis (shaft) and secondary ossification centers in the epiphyses. The primary ossification center is the first structure seen on ultrasound. Secondary ossification centers appear in the third trimester through the neonatal period, depending on the bone, although the cartilages of the epiphyses can be seen as hypoechogenic structures at the head of the femur and humerus much earlier.",
"   </p>",
"   <p>",
"    <strong>",
"     A short femur is defined as below the 5th percentile or below two standard deviations (SD) from the mean for the gestational age",
"    </strong>",
"    . This results in a pickup rate that exceeds the expected frequency of skeletal dysplasias. The differential diagnosis for a mildly shortened femur length should include normal variation, constitutional short limb, a false-positive measurement, intrauterine growth restriction (which may be due to placental factors, exposure to teratogens, or chromosome abnormalities), and aneuploidy (primarily Down syndrome).",
"   </p>",
"   <p>",
"    The following key points help in differential diagnosis when a short femur is detected on ultrasound:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The majority of isolated &ldquo;short&rdquo; femurs are normal or constitutionally short.",
"     </li>",
"     <li>",
"      As many as 13 percent of isolated &ldquo;short femurs&rdquo; diagnosed at 18 to 24 weeks are reclassified as normal on follow-up [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If interim growth over three to four weeks is normal, a skeletal dysplasia is unlikely. If femur length over this interval falls further from the mean, it should raise the question of skeletal dysplasia or severe growth restriction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Severe intrauterine growth restriction should be suspected if the short femur length is associated with a small abdominal circumference, abnormal placental morphology, or abnormal Doppler parameters (increased resistance in the uterine or umbilical arteries, evidence of redistribution in the middle cerebral arteries). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/23/22906?source=see_link\">",
"       \"Diagnosis of fetal growth restriction\"",
"      </a>",
"      .) Severe growth restriction has several fetal, maternal, and placental etiologies. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/23/10616?source=see_link\">",
"       \"Overview of causes of and risk factors for fetal growth restriction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Findings most predictive of skeletal dysplasia include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Femur length more than 5 mm below -2SD for gestational age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/25\">",
"       25",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Femur:foot length &lt;1 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/26\">",
"       26",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Femur length:abdominal circumference &lt;0.16 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/22\">",
"       22",
"      </a>",
"      ]",
"      <strong>",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The earlier in gestation a skeletal dysplasia is detected, the worse the prognosis. The majority of cases found in the first trimester represent lethal skeletal dysplasias [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33599767\">",
"    <span class=\"h2\">",
"     Secondary evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a short femur is identified in a fetus prior to 24 weeks of gestation, we recommend referral to a center with expertise in skeletal dysplasias to help determine the diagnosis. The components of detailed assessment are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef63933 \" href=\"mobipreview.htm?7/17/7453\">",
"     table 1",
"    </a>",
"    ) and discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348206\">",
"    <span class=\"h3\">",
"     Pattern of limb shortening",
"    </span>",
"    &nbsp;&mdash;&nbsp;All long bones (ie, each femur, humerus, radius, ulna, tibia, fibula) should be measured to determine the relative shortening against normative values. There are four main patterns of limb shortening:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rhizomelia, shortening of the proximal segment (femur and humerus)",
"     </li>",
"     <li>",
"      Mesomelia, shortening of the middle segment (radius, ulna, tibia, and fibula)",
"     </li>",
"     <li>",
"      Acromelia, shortening of the distal segment (hands and feet)",
"     </li>",
"     <li>",
"      Micromelia, shortening of all parts of the limb. Micromelia is further subdivided into mild, mild and bowed, or severe (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef54680 \" href=\"mobipreview.htm?4/26/4515\">",
"       image 2",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the majority of skeletal dysplasias, there is severe micromelia, but the foot is relatively spared. The femur:foot length ratio is normally 1.0 throughout the pregnancy, thus a ratio of less than 1 is useful in distinguishing skeletal dysplasia from other causes of short femur, such as fetal growth restriction or aneuploidy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348213\">",
"    <span class=\"h3\">",
"     Qualitative assessment of long bones",
"    </span>",
"    &nbsp;&mdash;&nbsp;An assessment should be made of shape, contour, mineralization, bowing, angulation, fractures, metaphyseal flaring, and absence of individual bones. The joints should be assessed for deformities.",
"   </p>",
"   <p>",
"    Although more than 40 distinct disorders are associated with",
"    <span class=\"nowrap\">",
"     bowing/bending/angulation",
"    </span>",
"    of the femurs, the majority belong to the following disorders: campomelic dysplasia, thanatophoric dysplasia (TD), achondroplasia, and osteogenesis imperfecta. Bone fractures may appear as angulations or interruptions in the bone contour or as thick, wrinkled contours corresponding to repetitive cycles of fracture and callus formation. Decreased or absent acoustic shadowing is a marker for reduced mineralization of the long bones, which may be found in osteogenesis imperfecta, achondrogenesis, and hypophosphatasia congenita. Abnormal epiphyseal calcifications suggest chondrodysplasia punctata.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33600189\">",
"    <span class=\"h3\">",
"     Assessment of other bones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific dysmorphic features of bones (eg, clavicular or scapular hypoplasia; aplasia of fibula, tibia, or radius; platyspondyly [flattened vertebral bodies]) can be helpful to further define a specific skeletal dysplasia. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348227\">",
"    <span class=\"h4\">",
"     Spine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spine is assessed for segmentation anomalies, kyphoscoliosis, platyspondyly, demineralization, myelodysplasia, and caudal regression. Although platyspondyly is the most common spine abnormality, it may be difficult to diagnose on prenatal ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348234\">",
"    <span class=\"h4\">",
"     Hands and feet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common deformities of the hands and feet include clubfoot, rocker bottom foot, clubhand, short fingers (brachydactyly), or an abnormal number of digits. The position of the thumbs and toes can provide a clue to the diagnosis; a hitchhiker or abducted",
"    <span class=\"nowrap\">",
"     thumb/first",
"    </span>",
"    toe is present in diastrophic dwarfism. Polydactyly (extra digits) suggests a group of conditions known as short-rib polydactyly syndromes (eg, Ellis&ndash;van Creveld syndrome, Jeune asphyxiating thoracic dystrophy, Saldino-Noonan) and some chromosomal abnormalities. Joint contractures suggest skeletal dysplasias associated with arthrogryposis multiplex congenita.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348241\">",
"    <span class=\"h4\">",
"     Calvarium",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most skeletal dysplasias with prenatal onset, the long bones are disproportionately short and the calvarium is normal or large. The most reliable sonographic sign of a lethal skeletal dysplasia with decreased mineralization is increased compressibility of the calvarium by the ultrasound probe, which suggests osteogenesis imperfecta type II, achondrogenesis, or hypophosphatasia. The cranium is also evaluated for macrocranium or microcephaly, frontal bossing, cloverleaf skull deformity, and underlying brain abnormalities. Temporal lobe dysplasia is associated with thanatophoric dysplasia (TD). An abnormal cranial contour may indicate craniosynostosis (premature fusion of the sutures).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348248\">",
"    <span class=\"h4\">",
"     Face",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common facial abnormalities include midface hypoplasia, saddle nose deformity, hypertelorism, cleft lip and palate, frontal bossing, micrognathia, and retrognathia (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65436 \" href=\"mobipreview.htm?3/39/3697\">",
"     image 3",
"    </a>",
"    ). The biorbital diameter should be measured to assess for hypotelorism or hypertelorism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348255\">",
"    <span class=\"h4\">",
"     Pelvic bones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although important to evaluate, the pelvic bones are difficult to assess on conventional two-dimensional (2D) ultrasound and additional three-dimensional (3D) techniques may be required to appreciate the shape of the iliac bones and the sacrosciatic notches.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33600291\">",
"    <span class=\"h3\">",
"     Other assessments",
"    </span>",
"    &nbsp;&mdash;&nbsp;A detailed evaluation of the cardiovascular, genitourinary, gastrointestinal (GI), and central nervous system (CNS) should be done concurrently with the musculoskeletal evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348269\">",
"    <span class=\"h1\">",
"     ADDITIONAL DIAGNOSTIC TECHNIQUES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33600351\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;When skeletal abnormalities are suspected on ultrasound examination, additional imaging modalities can provide additional information to help confirm the diagnosis or point to alternative diagnoses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348276\">",
"    <span class=\"h3\">",
"     Three-dimensional ultrasound (3D-US)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three-dimensional ultrasound is becoming an increasingly useful complement to two-dimensional ultrasound in diagnosis of skeletal dysplasia and pulmonary hypoplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/26,29-31\">",
"     26,29-31",
"    </a>",
"    ]. High contrast structures such as the fetal skeleton are especially amenable to 3D-US rendering software. Surface rendering capabilities are particularly useful to visualize subtle facial dysmorphism, such as low set or deformed ears, micrognathia, flattening of the facial profile associated with midface hypoplasia, cranial distortion due to craniostenosis, or assessing",
"    <span class=\"nowrap\">",
"     hand/foot",
"    </span>",
"    abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/26\">",
"     26",
"    </a>",
"    ]. However, there are insufficient published data to gauge the diagnostic performance of this modality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33600740\">",
"    <span class=\"h3\">",
"     Magnetic resonance imaging (MRI)",
"    </span>",
"    &nbsp;&mdash;&nbsp;After 20 weeks of gestation, MRI plays a complementary role to ultrasound because it can identify and better define some abnormalities, particularly of the spine, and has no known deleterious effects on the developing fetus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/32\">",
"     32",
"    </a>",
"    ]. MRI can also be useful in the context of &ldquo;virtual autopsy&rdquo; in families who have declined autopsy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348283\">",
"    <span class=\"h3\">",
"     Radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal radiography has a limited role in prenatal diagnosis because the superimposition of fetal and maternal bones makes interpretation difficult. Postnatal radiography, however, plays a critical role in defining the characteristic skeletal features present in many skeletal dysplasias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348290\">",
"    <span class=\"h3\">",
"     Three- dimensional computed tomography (3D-CT)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal 3D-CT can provide more detailed images of spine and pelvic bone morphology than ultrasound; however, fetal radiation exposure is in the 3 mGy range [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/26,33-35\">",
"     26,33-35",
"    </a>",
"    ], thus restricting its use to limited circumstances. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .) Postnatally, 3D-CT can be useful in the context of &ldquo;virtual autopsy&rdquo; in families who have declined autopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33600788\">",
"    <span class=\"h2\">",
"     Invasive procedures for molecular diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chorionic villus sampling (performed transcervically at 11 to 14 weeks of gestation or transabdominally after 11 weeks of gestation) or amniocentesis (performed at &ge;15 weeks of gestation) are methods for obtaining fetal DNA. The fetal DNA is analyzed for gene mutations in a fetus known to be at risk for having skeletal dysplasia because of an affected parent (for autosomal dominant conditions), a carrier mother (for an X-linked condition), or parents identified as being carriers of an autosomal recessive skeletal dysplasia (due to a personal or family history of an affected",
"    <span class=\"nowrap\">",
"     baby/fetus).",
"    </span>",
"    Genetic defects have been identified for approximately 70 percent of the over 456 skeletal dysplasias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/3\">",
"     3",
"    </a>",
"    ] and can be used to provide early prenatal diagnosis (before diagnostic findings are seen on ultrasound) or preimplantation diagnosis in at-risk families, or to confirm the presumptive diagnosis on imaging performed later in pregnancy. A fetal karyotype or microarray analysis is usually performed at the same time. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/2/7208?source=see_link\">",
"     \"Use of array comparative genomic hybridization (aCGH) in obstetrics\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For couples with a prior affected fetus due to a new dominant disorder, there is no consensus whether molecular diagnosis should be performed for a relatively low risk of germline mosaicism. In most of these cases, the risk for a miscarriage associated with the prenatal invasive procedure is higher than the risk for the fetus to be affected; furthermore, fetal ultrasound is reliable in making a relatively early diagnosis. Likewise, the role of molecular diagnosis for a skeletal dysplasia in an ongoing pregnancy is controversial since the time necessary for DNA analysis can be lengthy and a negative result or failure to identify a specific mutation does not change the clinical implications derived from the ultrasound findings.",
"   </p>",
"   <p>",
"    When both parents are affected with the same or different autosomal dominant skeletal disorders, the fetus is at high risk of lethality because of homozygosity or compound heterozygosity for the same condition, or heterozygosity for two dominant conditions (double heterozygote) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/37\">",
"     37",
"    </a>",
"    ]. In such cases, molecular diagnosis is useful to distinguish between a heterozygous and homozygous fetus. This is important in cases where both parents have achondroplasia and the mutation is known (the detection rate of a mutation in the causative gene, fibroblast growth factor receptor 3 [FGFR3], is 99 percent; c&gt;1138G&gt;A (p.Gly380Arg) mutation in about 98 percent of cases and c&gt;1138G&gt;C (p.Gly380Arg) in about 1 percent of the cases) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/1\">",
"     1",
"    </a>",
"    ]. The FGFR3 gene is also associated with isolated craniosynostosis, thanatophoric dysplasia (TD), and some cases of hypochondroplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Ideally, the gene and gene mutation will have been identified in the parents before pregnancy since the process of mutation analysis can be lengthy.",
"   </p>",
"   <p>",
"    If the risk of an affected fetus is relatively low, as when one parent has an autosomal recessive skeletal dysplasia, the appropriateness of molecular diagnosis is less clear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33599954\">",
"    <span class=\"h1\">",
"     COUNSELING",
"    </span>",
"    &nbsp;&mdash;&nbsp;When ultrasound and any additional diagnostic evaluation lead to diagnosis of a specific skeletal dysplasia, parents can be given prognostic information. When the diagnosis is uncertain, the most important determination that needs to be made is whether the condition is lethal (resulting in intrauterine death or neonatal demise).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544667513\">",
"    <span class=\"h2\">",
"     Prediction of lethality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prediction of lethality on prenatal ultrasound is highly accurate, ranging from 81 to more than 99 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/6-8,40\">",
"     6-8,40",
"    </a>",
"    ]. In the largest prospective study, analysis of data from 500 cases in the International Skeletal Dysplasia Registry accurately predicted lethality in 96.8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to use multiple sonographic parameters to obtain the most accurate diagnosis of lethality (caused by the pulmonary hypoplasia associated with the small chest circumference) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/41\">",
"     41",
"    </a>",
"    ]. Findings suggestive of pulmonary hypoplasia include (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59648 \" href=\"mobipreview.htm?25/19/25912\">",
"     image 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thoracic circumference &lt;5th percentile, measured at the level of the four-chamber heart view",
"     </li>",
"     <li>",
"      Thoracic:abdominal circumference ratio &lt;0.6 to 0.79 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/42-45\">",
"       42-45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Short thoracic length (from the neck to the diaphragm compared to nomograms)",
"     </li>",
"     <li>",
"      Ribs that encircle less than 70 percent of the thoracic circumference at the level of the four-chamber cardiac view [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/46\">",
"       46",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Markedly narrowed anteroposterior (AP) diameter (sagittal view)",
"     </li>",
"     <li>",
"      Concave or bell-shaped contour of the thorax (coronal view)",
"     </li>",
"     <li>",
"      Femur length:abdominal circumference &lt;0.16 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/47\">",
"       47",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A comparative study of eight different methods for the prediction of fetal lung hypoplasia determined that the lung volumes and the thoracic circumference to abdominal circumference ratios performed best [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/48\">",
"     48",
"    </a>",
"    ]; however, the majority of these studies were performed in the congenital diaphragmatic hernia population and may not be generalizable to this population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544667520\">",
"    <span class=\"h2\">",
"     Pregnancy management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The finding of a lethal skeletal dysplasia and the subsequent communication of bad news are difficult tasks, which require empathy and support. In many cases, the exact diagnosis is not known, but the prognosis is evident based on the ultrasound findings",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the findings on molecular analysis. The fetal findings and the implications should be explained in language that is simple to understand so that the parents can make an informed decision regarding the management of the pregnancy and possible delivery and postnatal care. Cultural differences need to be respected and taken into consideration during the counselling process. The parents should be presented with the following three options:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Continue the pregnancy with repeated fetal ultrasound and counselling by medical geneticists, neonatologists and perinatologists regarding the management of delivery and postnatal care. The mode of delivery, especially in cases with fetal macrocrania (which may preclude vaginal delivery), and the extent of postnatal treatment should be discussed, and the poor prognosis should be kept in mind.",
"     </li>",
"     <li>",
"      Pregnancy termination",
"     </li>",
"     <li>",
"      Obtain further information prior to making a decision, with the help of others, such as medical geneticists, neonatologists, orthopedic surgeons, palliative treatment groups, social workers,",
"      <span class=\"nowrap\">",
"       organizations/groups",
"      </span>",
"      of other affected families, and the parents&rsquo; religious or community sources of support.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33601374\">",
"    <span class=\"h2\">",
"     Postnatal/posttermination evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal autopsy should be offered to identify the etiology of the skeletal dysplasia, especially if the diagnosis is uncertain or the results will affect the future reproductive plans of the couple [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/51\">",
"     51",
"    </a>",
"    ]. For example, if there is an increased risk of recurrence, some couples may choose to have preimplantation genetic diagnosis,",
"    <span class=\"nowrap\">",
"     egg/sperm/embryo",
"    </span>",
"    donation, early prenatal diagnosis, or avoid subsequent pregnancy.",
"   </p>",
"   <p>",
"    With parental consent, external and internal examinations are performed and skeletal x-rays and photographs are taken. Histopathological examination of bones, relevant tissue and the placenta should be performed. The femur is the most useful bone, as it offers bone and cartilaginous tissue in addition to two large growth plates. Bone and cartilage may be kept deep frozen for later studies. Chromosomal analysis should be attempted and tissue should be referred for DNA extraction and banking, as well as fibroblast banking in the event that molecular analysis and microarray analysis will be indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H454259399\">",
"    <span class=\"h3\">",
"     Resources",
"    </span>",
"    &nbsp;&mdash;&nbsp;When local expertise is unavailable",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the diagnosis cannot be determined, resources such as the International Skeletal Dysplasia Registry or the European Skeletal Dysplasia network should be consulted. Detailed and up-to-date information regarding the molecular tests available for the diagnosis of skeletal dysplasias is available at:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      GeneTests (a comprehensive source of information on genetic testing funded by the US National Institutes of Health): (",
"      <a class=\"external\" href=\"file://genetests.org/\">",
"       file://genetests.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      European Skeletal Dysplasia Network (",
"      <a class=\"external\" href=\"file://www.esdn.org/\">",
"       file://www.esdn.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Division of Molecular Pediatrics of the University of Lausanne, Switzerland (",
"      <a class=\"external\" href=\"file://www.pediatrics.ch/Frames.html\">",
"       file://www.pediatrics.ch/Frames.html",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      International Skeletal Dysplasia (",
"      <a class=\"external\" href=\"file://www.skeldys.org/\">",
"       www.skeldys.org",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348318\">",
"    <span class=\"h1\">",
"     SYNOPSIS OF SPECIFIC LETHAL SKELETAL DYSPLASIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lethal skeletal dysplasias are characterized by severe micromelia and a small chest, which inhibits lung development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/53\">",
"     53",
"    </a>",
"    ]. The most important determinant of lethality is the degree of pulmonary hypoplasia. When a lethal skeletal dysplasia is suspected because of severe micromelia, early onset",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a small chest, the more common types can be distinguished from one another by four key features: bone mineralization, fractures, macrocranium (disproportionately large head), and short trunk (",
"    <a class=\"graphic graphic_table graphicRef50414 \" href=\"mobipreview.htm?30/33/31259\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In many fetal skeletal dysplasias, the skin and subcutaneous layers continue to grow at a faster rate than the long bones, resulting in relatively thickened skin folds, which may be mistaken for hydrops fetalis. Polyhydramnios is common and may be related to a combination of factors, including esophageal compression (by the small chest), micrognathia, associated gastrointestinal abnormalities, and hypotonia.",
"   </p>",
"   <p>",
"    The more common lethal skeletal dysplasias occur in less than 1 in 10,000 births and the rare types occur is less than 1 in 100,000 births.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348325\">",
"    <span class=\"h2\">",
"     Thanatophoric dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thanatophoric dysplasia (TD) is the most common lethal skeletal dysplasia, with a prevalence of 0.24 to 0.69 per 10,000 births. Some characteristic features are (",
"    <a class=\"graphic graphic_table graphicRef50414 \" href=\"mobipreview.htm?30/33/31259\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe micromelia with rhizomelic predominance. Typically, the extremities are so foreshortened that they protrude at right angles to the body.",
"     </li>",
"     <li>",
"      Small thoracic circumference",
"     </li>",
"     <li>",
"      Macrocrania",
"     </li>",
"     <li>",
"      Normal trunk length",
"     </li>",
"     <li>",
"      Normal mineralization",
"     </li>",
"     <li>",
"      No fractures",
"     </li>",
"     <li>",
"      Thickened, redundant skin folds",
"     </li>",
"     <li>",
"      Platyspondyly (flattened vertebral bodies)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Type 1 (TD1) TD is the more common form of TD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/29,38,54\">",
"     29,38,54",
"    </a>",
"    ] and is usually caused by R248C and Y373C mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. The appearance of TD1 includes the typical &ldquo;telephone receiver&rdquo; shape of the femur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/29,38\">",
"     29,38",
"    </a>",
"    ], along with frontal bossing and midface hypoplasia, but no cloverleaf skull deformity.",
"   </p>",
"   <p>",
"    Type 2 (TD2) TD is usually caused by the K650E mutation in the FGFR3 gene. The femurs are typically straight with flared metaphyses. The most specific feature of TD2 is the cloverleaf skull: a trilobed appearance of the skull in the coronal plane that results from premature craniosynostosis of the lambdoid and coronal sutures.",
"   </p>",
"   <p>",
"    Both TD1 and TD2 are autosomal dominant conditions, with all cases caused by new mutations in the FGFR3 gene. TD has many phenotypic similarities to homozygous achondroplasia, but the latter is distinguished by the positive family history [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/53,55\">",
"     53,55",
"    </a>",
"    ] in which both parents have achondroplasia (heterozygous for the specific FGFR3 mutations associated with achondroplasia).",
"   </p>",
"   <p>",
"    Polyhydramnios is present in approximately 50 percent of affected fetuses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TD is associated with brain abnormalities, specifically, temporal lobes enlargement, polymicrogyria, and deep and transverse temporal sulci, which can be seen on brain autopsy at 18 weeks of gestation. The abnormal deep transverse sulci in the temporal lobes can be visualized on fetal ultrasound at 20 weeks of gestation and can help in confirming the diagnosis if the",
"    <span class=\"nowrap\">",
"     couple/woman",
"    </span>",
"    decides not to have amniocentesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/57\">",
"     57",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348332\">",
"    <span class=\"h2\">",
"     Achondrogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Achondrogenesis is the second most common lethal skeletal dysplasia, with a prevalence of 0.09 to 0.23 per 10,000 births. Although a phenotypically and genetically diverse group of chondrodysplasias, they share the following characteristic ultrasound features (",
"    <a class=\"graphic graphic_table graphicRef50414 \" href=\"mobipreview.htm?30/33/31259\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/10,58-60\">",
"     10,58-60",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe micromelia",
"     </li>",
"     <li>",
"      Small thoracic circumference",
"     </li>",
"     <li>",
"      Macrocrania",
"     </li>",
"     <li>",
"      Short trunk length",
"     </li>",
"     <li>",
"      Decreased mineralization, most marked in the vertebral bodies, ischium, and pubic bones",
"     </li>",
"     <li>",
"      Occasional fractures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Type 1 achondrogenesis (20 percent of cases) has autosomal recessive mode of inheritance and thus has a 25 percent recurrence risk. In addition to decreased mineralization of the vertebral column, sacrum and pubic bones, Type 1 achondrogenesis is also associated with calvarial demineralization. Type 1A is caused by a mutation in the TRIP11 gene (Golgi-microtubule-associated protein, 210-kDa, GMAP210) and type 1B is associated with a mutation in the DTDST gene (SLC26A2 sulfate transporter).",
"   </p>",
"   <p>",
"    Type 2 achondrogenesis (80 percent of cases) is an autosomal dominant condition caused by a new dominant mutation in the COL2A1 gene, which encodes type II collagen. The recurrence risk is very small.",
"   </p>",
"   <p>",
"    Polyhydramnios is present in approximately 25 percent of affected fetuses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348339\">",
"    <span class=\"h2\">",
"     Osteogenesis imperfecta type 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteogenesis imperfecta is a clinically and genetically heterogeneous group of collagen disorders characterized by brittle bones that are prone to fracture. It has been classified into four major subtypes based on genetic, radiographic, and clinical considerations, but additional less common types also exist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/9/38040?source=see_link\">",
"     \"Osteogenesis imperfecta: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/36/26185?source=see_link\">",
"     \"Osteogenesis imperfecta: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Individuals with type II osteogenesis imperfecta usually die in utero or in early infancy due to severe fractures and pulmonary hypoplasia (",
"    <a class=\"graphic graphic_table graphicRef50414 \" href=\"mobipreview.htm?30/33/31259\">",
"     table 2",
"    </a>",
"    ). The key ultrasound features are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/63\">",
"     63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe micromelia, with femur length more than 3 SD below the mean for gestational age",
"     </li>",
"     <li>",
"      Small thoracic circumference",
"     </li>",
"     <li>",
"      Normal cranial size",
"     </li>",
"     <li>",
"      Short trunk length",
"     </li>",
"     <li>",
"      Decreased mineralization",
"     </li>",
"     <li>",
"      Multiple bone fractures, including multiple fractures within a single bone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The demineralized bones have multiple angulations and thickening due to innumerable fractures and repetitive callus formation. Multiple rib fractures result in a concave thoracic contour, most evident at the lateral thorax where the elbows &ldquo;bash&rdquo; in the fragile rib cage (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54731 \" href=\"mobipreview.htm?34/7/34930\">",
"     image 5",
"    </a>",
"    ). Demineralization of the cranium causes it to deform upon gentle pressure with the ultrasound transducer (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69521 \" href=\"mobipreview.htm?14/60/15302\">",
"     image 6",
"    </a>",
"    ). Platyspondyly and micrognathia are commonly present.",
"   </p>",
"   <p>",
"    The diagnosis may be made sonographically as early as 13 to 15 weeks of gestational age. A normal ultrasound examination after 17 weeks virtually excludes this diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348346\">",
"    <span class=\"h2\">",
"     Hypophosphatasia congenita",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypophosphatasia congenita is an autosomal recessive skeletal dysplasia mapped to 1p36.1-p34 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/64\">",
"     64",
"    </a>",
"    ] and associated with low levels of alkaline phosphatase. The key ultrasound features are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe micromelia",
"     </li>",
"     <li>",
"      Small thoracic circumference",
"     </li>",
"     <li>",
"      Normal cranial size",
"     </li>",
"     <li>",
"      Normal trunk length",
"     </li>",
"     <li>",
"      Decreased mineralization",
"     </li>",
"     <li>",
"      Occasional fractures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The cranium is demineralized and compressible. The bones appear thin, delicate or entirely absent, with occasional fractures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348353\">",
"    <span class=\"h2\">",
"     Campomelic dysplasia or bent-limb dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Campomelic dysplasia or bent-limb dysplasia is a rare autosomal-dominant condition, usually the result of a new dominant mutation in the SOX9 gene (sex-determining protein homeobox 9 mapped to 17q24.3). Most cases (77 percent) are lethal because of respiratory insufficiency from laryngotracheomalacia in combination with a mildly narrowed thorax.",
"   </p>",
"   <p>",
"    Ultrasound features may include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypoplastic scapula and cervical vertebrae (present in 63 percent of cases)",
"     </li>",
"     <li>",
"      Short femur and tibia that are ventrally bowed. Bowing may also occur in the upper extremities.",
"     </li>",
"     <li>",
"      Hypoplastic or absent fibula",
"     </li>",
"     <li>",
"      Talipes equinovarus (clubfoot)",
"     </li>",
"     <li>",
"      Late ossification of midthoracic pedicles",
"     </li>",
"     <li>",
"      Dislocated hips",
"     </li>",
"     <li>",
"      11 rib pairs",
"     </li>",
"     <li>",
"      Facial abnormalities, including micrognathia and cleft palate (Robin sequence)",
"     </li>",
"     <li>",
"      Congenital heart disease (present in 33 percent of cases)",
"     </li>",
"     <li>",
"      Brain abnormalities",
"     </li>",
"     <li>",
"      Renal abnormalities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Phenotypic sex reversal can be observed in about 75 percent of affected genotypic males (46, XY), with a gradation of defects ranging from ambiguous genitalia to normal female external genitalia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348360\">",
"    <span class=\"h2\">",
"     Short-rib polydactyly syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Short-rib polydactyly dysplasias are a heterogeneous group of rare and lethal skeletal dysplasias with an autosomal recessive mode of inheritance. They are subdivided into four groups: type I&mdash;Saldino-Noonan; type II&mdash;Majewski; type III&mdash;Verma-Naumoff; and type IV&mdash;Beemer-Langer (which can occur without polydactyly) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/64,68\">",
"     64,68",
"    </a>",
"    ]. Radiographic and clinical features can distinguish them. A few genes associated with this group of conditions have been identified and thus prenatal diagnosis using DNA analysis is possible in some of the cases.",
"   </p>",
"   <p>",
"    Ultrasound features may include (",
"    <a class=\"graphic graphic_table graphicRef50414 \" href=\"mobipreview.htm?30/33/31259\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe micromelia (present in 100 percent of cases)",
"     </li>",
"     <li>",
"      Small thoracic circumference (present in 100 percent of cases)",
"     </li>",
"     <li>",
"      Normal cranial size",
"     </li>",
"     <li>",
"      Normal bone mineralization",
"     </li>",
"     <li>",
"      Polydactyly",
"     </li>",
"     <li>",
"      Cardiac abnormalities",
"     </li>",
"     <li>",
"      Genitourinary abnormalities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ellis&ndash;van Creveld syndrome and Jeune asphyxiating thoracic dystrophy are short-rib polydactyly dysplasias. They have similar features, but less severe micromelia and thoracic narrowing than the short-rib polydactyly syndromes and are not associated with",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    lethality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2350072\">",
"    <span class=\"h2\">",
"     Fibrochondrogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibrochondrogenesis is a rare lethal osteochondrodysplasia with an autosomal recessive mode of inheritance. Ultrasound features include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Micromelia with metaphyseal flaring (dumbbell shape)",
"     </li>",
"     <li>",
"      Small thoracic circumference",
"     </li>",
"     <li>",
"      Normal cranial size",
"     </li>",
"     <li>",
"      Flat facies",
"     </li>",
"     <li>",
"      Decreased mineralization of the skull",
"     </li>",
"     <li>",
"      Vertebrae display platyspondyly and midline clefts",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The short long bones have irregular metaphyses with peripheral spurs and extra-articular calcifications, giving the appearance of stippling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348376\">",
"    <span class=\"h2\">",
"     Atelosteogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atelosteogenesis is a rare lethal osteochondrodysplasia and represents a heterogenous group of disorders with the following ultrasound features:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe micromelia associated with hypoplasia of the distal femur and humerus",
"     </li>",
"     <li>",
"      Bowed long bones",
"     </li>",
"     <li>",
"      Flat facies",
"     </li>",
"     <li>",
"      Narrow chest with short ribs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Facial clefts and dislocations of the knee and elbow can occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348383\">",
"    <span class=\"h2\">",
"     Chondrodysplasia punctata or stippled epiphyses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chondrodysplasia punctata or stippled epiphyses is etiologically a heterogeneous group of disorders with many small calcifications (ossification centers) in the cartilage, the ends of bones, and around the spine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/71,72\">",
"     71,72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rhizomelic form of chondrodysplasia punctata is an autosomal-recessive condition that appears as severe, symmetrical, predominantly rhizomelic limb shortening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/37/42585/abstract/64,73\">",
"     64,73",
"    </a>",
"    ]. It is associated with severe mental retardation and is generally lethal before the second year of life. The condition is the result of peroxisomal dysfunction and can be associated with low unconjugated estriol concentration on second trimester screening for Down syndrome. The enlarged epiphyses with characteristic stippling may be identified on ultrasound in the third trimester. The humeri tend to be relatively shorter than the femurs and have metaphyseal cupping. Other abnormalities include dysmorphic facial features, joint contractures, coronal clefting of the vertebral bodies, and brain abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348390\">",
"    <span class=\"h2\">",
"     Other lethal skeletal dysplasias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other lethal skeletal dysplasias include Boomerang dysplasia, de la Chapelle dysplasia, and Schneckenbecken dysplasia. These are rare and difficult to diagnose accurately on prenatal ultrasound.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2350151\">",
"    <span class=\"h2\">",
"     Variably lethal skeletal dysplasias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skeletal dysplasias that are variably lethal are the most challenging for prenatal ultrasound diagnosis. Two of the more common entities in this group are Jeune Asphyxiating Thoracic Dysplasia and Chondroectodermal Dysplasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2348413\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The lethal skeletal dysplasias comprise a heterogenous and complex group of conditions that affect bone growth and development. The three most common conditions detected prenatally are thanatophoric dysplasia (TD), osteogenesis imperfect type 2 and achondrogenesis. (See",
"      <a class=\"local\" href=\"#H2348162\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2348169\">",
"       'Prevalence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two-dimensional ultrasound is the primary imaging modality used for the initial assessment of a potentially affected fetus. (See",
"      <a class=\"local\" href=\"#H2348190\">",
"       'Ultrasound evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When fetal skeletal dysplasia is suspected on ultrasound (eg, femur length below 2 standard deviations below the mean for gestational age), the patient should be referred promptly to a tertiary center for specialized fetal evaluation (",
"      <a class=\"graphic graphic_table graphicRef63933 \" href=\"mobipreview.htm?7/17/7453\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef50414 \" href=\"mobipreview.htm?30/33/31259\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H33599767\">",
"       'Secondary evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When both parents are affected with the same or different autosomal dominant skeletal disorders, the fetus is at high risk of lethality because of homozygosity or compound heterozygosity (for the same condition) or heterozygosity for two dominant conditions (double heterozygosity). In such cases, it is useful to identify the parental mutations before pregnancy and offer prenatal or preimplantation genetic diagnosis. (See",
"      <a class=\"local\" href=\"#H33600788\">",
"       'Invasive procedures for molecular diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The primary role of antenatal diagnosis is to predict lethality. It is important to use multiple parameters, such as a thoracic circumference below the 5",
"      <sup>",
"       th",
"      </sup>",
"      percentile, an abnormal thoracic:abdominal circumference, and a markedly narrowed sagittal anteroposterior diameter of the thorax to diagnose lethality. Secondary goals are to determine the diagnosis or narrow the differential diagnosis. (See",
"      <a class=\"local\" href=\"#H2348183\">",
"       'Overview of prenatal diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H544667513\">",
"       'Prediction of lethality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once a determination regarding the lethality and possible diagnosis is made, the couple should be counselled and given options by a team which includes perinatal imaging specialists, medical geneticists, maternal-fetal medicine specialists, and neonatologists. If both parents have skeletal dysplasia, their diagnoses should be determined and the implications of these diagnoses on their pregnancy should be discussed, including the mode of delivery and postnatal treatment. (See",
"      <a class=\"local\" href=\"#H33599954\">",
"       'Counseling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After delivery or pregnancy termination, the diagnosis should be confirmed by clinical, radiographic, photographic and histomorphic analysis. Cell culture and DNA should be banked and used for further molecular investigation. The parents should be seen again to discuss the results and the implications these may have on their future reproductive plans. (See",
"      <a class=\"local\" href=\"#H33601374\">",
"       'Postnatal/posttermination evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/1\">",
"      Krakow D, Lachman RS, Rimoin DL. Guidelines for the prenatal diagnosis of fetal skeletal dysplasias. Genet Med 2009; 11:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/2\">",
"      Superti-Furga A. Growing bone knowledge. Clin Genet 2004; 66:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/3\">",
"      Warman ML, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 2011; 155A:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/4\">",
"      Olsen BR, Reginato AM, Wang W. Bone development. Annu Rev Cell Dev Biol 2000; 16:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/5\">",
"      Ngo C, Viot G, Aubry MC, et al. First-trimester ultrasound diagnosis of skeletal dysplasia associated with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2007; 30:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/6\">",
"      Krakow D, Alanay Y, Rimoin LP, et al. Evaluation of prenatal-onset osteochondrodysplasias by ultrasonography: a retrospective and prospective analysis. Am J Med Genet A 2008; 146A:1917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/7\">",
"      Schramm T, Gloning KP, Minderer S, et al. Prenatal sonographic diagnosis of skeletal dysplasias. Ultrasound Obstet Gynecol 2009; 34:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/8\">",
"      Tretter AE, Saunders RC, Meyers CM, et al. Antenatal diagnosis of lethal skeletal dysplasias. Am J Med Genet 1998; 75:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/9\">",
"      Doray B, Favre R, Viville B, et al. Prenatal sonographic diagnosis of skeletal dysplasias. A report of 47 cases. Ann Genet 2000; 43:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/10\">",
"      Hall CM. International nosology and classification of constitutional disorders of bone (2001). Am J Med Genet 2002; 113:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/11\">",
"      Rasmussen SA, Bieber FR, Benacerraf BR, et al. Epidemiology of osteochondrodysplasias: changing trends due to advances in prenatal diagnosis. Am J Med Genet 1996; 61:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/12\">",
"      Camera G, Mastroiacovo P. Birth prevalence of skeletal dysplasias in the Italian Multicentric Monitoring System for Birth Defects. Prog Clin Biol Res 1982; 104:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/13\">",
"      Weldner BM, Persson PH, Ivarsson SA. Prenatal diagnosis of dwarfism by ultrasound screening. Arch Dis Child 1985; 60:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/14\">",
"      Andersen PE Jr. Prevalence of lethal osteochondrodysplasias in Denmark. Am J Med Genet 1989; 32:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/15\">",
"      Waller DK, Correa A, Vo TM, et al. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A 2008; 146A:2385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/16\">",
"      Connor JM, Connor RA, Sweet EM, et al. Lethal neonatal chondrodysplasias in the West of Scotland 1970-1983 with a description of a thanatophoric, dysplasialike, autosomal recessive disorder, Glasgow variant. Am J Med Genet 1985; 22:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/17\">",
"      K&auml;ll&eacute;n B, Knudsen LB, Mutchinick O, et al. Monitoring dominant germ cell mutations using skeletal dysplasias registered in malformation registries: an international feasibility study. Int J Epidemiol 1993; 22:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/18\">",
"      Orioli IM, Castilla EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet 1986; 23:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/19\">",
"      Castilla EE, Orioli IM. Prevalence rates of microtia in South America. Int J Epidemiol 1986; 15:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/20\">",
"      Khalil A, Pajkrt E, Chitty LS. Early prenatal diagnosis of skeletal anomalies. Prenat Diagn 2011; 31:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/21\">",
"      Sharony R, Browne C, Lachman RS, Rimoin DL. Prenatal diagnosis of the skeletal dysplasias. Am J Obstet Gynecol 1993; 169:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/22\">",
"      Parilla BV, Leeth EA, Kambich MP, et al. Antenatal detection of skeletal dysplasias. J Ultrasound Med 2003; 22:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/23\">",
"      Gaffney G, Manning N, Boyd PA, et al. Prenatal sonographic diagnosis of skeletal dysplasias--a report of the diagnostic and prognostic accuracy in 35 cases. Prenat Diagn 1998; 18:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/24\">",
"      Papageorghiou AT, Fratelli N, Leslie K, et al. Outcome of fetuses with antenatally diagnosed short femur. Ultrasound Obstet Gynecol 2008; 31:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/25\">",
"      Kurtz AB, Needleman L, Wapner RJ, et al. Usefulness of a short femur in the in utero detection of skeletal dysplasias. Radiology 1990; 177:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/26\">",
"      Ruano R, Molho M, Roume J, Ville Y. Prenatal diagnosis of fetal skeletal dysplasias by combining two-dimensional and three-dimensional ultrasound and intrauterine three-dimensional helical computer tomography. Ultrasound Obstet Gynecol 2004; 24:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/27\">",
"      Campbell J, Henderson A, Campbell S. The fetal femur/foot length ratio: a new parameter to assess dysplastic limb reduction. Obstet Gynecol 1988; 72:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/28\">",
"      Rouse GA, Filly RA, Toomey F, Grube GL. Short-limb skeletal dysplasias: evaluation of the fetal spine with sonography and radiography. Radiology 1990; 174:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/29\">",
"      Chen CP, Chern SR, Shih JC, et al. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia. Prenat Diagn 2001; 21:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/30\">",
"      Garjian KV, Pretorius DH, Budorick NE, et al. Fetal skeletal dysplasia: three-dimensional US--initial experience. Radiology 2000; 214:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/31\">",
"      Vergani P, Andreani M, Greco M, et al. Two- or three-dimensional ultrasonography: which is the best predictor of pulmonary hypoplasia? Prenat Diagn 2010; 30:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/32\">",
"      Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 2007; 188:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/33\">",
"      Cassart M, Massez A, Cos T, et al. Contribution of three-dimensional computed tomography in the assessment of fetal skeletal dysplasia. Ultrasound Obstet Gynecol 2007; 29:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/34\">",
"      Breidt D, Bouquigny F, Cl&eacute;ment JP, et al. [Helical CT pelvimetry: advantages of a low dose volume acquisition technique]. J Radiol 2003; 84:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/35\">",
"      Felmlee JP, Gray JE, Leetzow ML, Price JC. Estimated fetal radiation dose from multislice CT studies. AJR Am J Roentgenol 1990; 154:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/36\">",
"      Mac&eacute; G, Sonigo P, Cormier-Daire V, et al. Use of 3D helical computed tomography in the prenatal diagnosis of fetal skeletal dysplasia. Ultrasound Obstet Gynecol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/37\">",
"      Unger S, Korkko J, Krakow D, et al. Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita. Am J Med Genet 2001; 104:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/38\">",
"      Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 2000; 21:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/39\">",
"      Tavormina PL, Shiang R, Thompson LM, et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995; 9:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/40\">",
"      Yeh P, Saeed F, Paramasivam G, et al. Accuracy of prenatal diagnosis and prediction of lethality for fetal skeletal dysplasias. Prenat Diagn 2011; 31:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/41\">",
"      Hersh JH, Angle B, Pietrantoni M, et al. Predictive value of fetal ultrasonography in the diagnosis of a lethal skeletal dysplasia. South Med J 1998; 91:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/42\">",
"      Songster GS, Gray DL, Crane JP. Prenatal prediction of lethal pulmonary hypoplasia using ultrasonic fetal chest circumference. Obstet Gynecol 1989; 73:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/43\">",
"      Nimrod C, Davies D, Iwanicki S, et al. Ultrasound prediction of pulmonary hypoplasia. Obstet Gynecol 1986; 68:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/44\">",
"      Merz E, Miric-Tesanic D, Bahlmann F, et al. Prenatal sonographic chest and lung measurements for predicting severe pulmonary hypoplasia. Prenat Diagn 1999; 19:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/45\">",
"      Johnson A, Callan NA, Bhutani VK, et al. Ultrasonic ratio of fetal thoracic to abdominal circumference: an association with fetal pulmonary hypoplasia. Am J Obstet Gynecol 1987; 157:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/46\">",
"      Dugoff L, Coffin CT, Hobbins JC. Sonographic measurement of the fetal rib cage perimeter to thoracic circumference ratio: application to prenatal diagnosis of skeletal dysplasias. Ultrasound Obstet Gynecol 1997; 10:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/47\">",
"      Rahemtullah A, McGillivray B, Wilson RD. Suspected skeletal dysplasias: femur length to abdominal circumference ratio can be used in ultrasonographic prediction of fetal outcome. Am J Obstet Gynecol 1997; 177:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/48\">",
"      Yoshimura S, Masuzaki H, Gotoh H, et al. Ultrasonographic prediction of lethal pulmonary hypoplasia: comparison of eight different ultrasonographic parameters. Am J Obstet Gynecol 1996; 175:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/49\">",
"      Rypens F, Metens T, Rocourt N, et al. Fetal lung volume: estimation at MR imaging-initial results. Radiology 2001; 219:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/50\">",
"      Williams G, Coakley FV, Qayyum A, et al. Fetal relative lung volume: quantification by using prenatal MR imaging lung volumetry. Radiology 2004; 233:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/51\">",
"      Chitayat D, Babul-Hirji R. Genetic counselling in prenatally diagnosed non-chromosomal fetal abnormalities. Curr Opin Obstet Gynecol 2000; 12:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/52\">",
"      Sankar VH, Phadke SR. Clinical utility of fetal autopsy and comparison with prenatal ultrasound findings. J Perinatol 2006; 26:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/53\">",
"      Lemyre E, Azouz EM, Teebi AS, et al. Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update. Can Assoc Radiol J 1999; 50:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/54\">",
"      Langer LO Jr, Yang SS, Hall JG, et al. Thanatophoric dysplasia and cloverleaf skull. Am J Med Genet Suppl 1987; 3:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/55\">",
"      Chitayat D, Fernandez B, Gardner A, et al. Compound heterozygosity for the Achondroplasia-hypochondroplasia FGFR3 mutations: prenatal diagnosis and postnatal outcome. Am J Med Genet 1999; 84:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/56\">",
"      Thomas RL, Hess LW, Johnson TR. Prepartum diagnosis of limb-shortening defects with associated hydramnios. Am J Perinatol 1987; 4:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/57\">",
"      Blaas HG, Vogt C, Eik-Nes SH. Abnormal gyration of the temporal lobe and megalencephaly are typical features of thanatophoric dysplasia and can be visualized prenatally by ultrasound. Ultrasound Obstet Gynecol 2012; 40:230.",
"     </a>",
"    </li>",
"    <li>",
"     Taybi, H, Lachman, RS. Radiology of syndromes, metabolic disorders, and skeletal dysplasias, 3rd, Year Book Medical Publishers, Chicago 1990.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/59\">",
"      DiMaio MS, Barth R, Koprivnikar KE, et al. First-trimester prenatal diagnosis of osteogenesis imperfecta type II by DNA analysis and sonography. Prenat Diagn 1993; 13:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/60\">",
"      Latini G, De Felice C, Parrini S, et al. Polyhydramnios: a predictor of severe growth impairment in achondroplasia. J Pediatr 2002; 141:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/61\">",
"      Sillence DO, Barlow KK, Garber AP, et al. Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet 1984; 17:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/62\">",
"      Barnes AM, Carter EM, Cabral WA, et al. Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med 2010; 362:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/63\">",
"      Munoz C, Filly RA, Golbus MS. Osteogenesis imperfecta type II: prenatal sonographic diagnosis. Radiology 1990; 174:181.",
"     </a>",
"    </li>",
"    <li>",
"     Meizner, I, Bar-Ziv, J. In utero diagnosis of skeletal disorders: an atlas of prenatal sonographic and postnatal radiologic correlation, CRC Press, Boca Raton FL 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/65\">",
"      Irving MD, Chitty LS, Mansour S, Hall CM. Chondrodysplasia punctata: a clinical diagnostic and radiological review. Clin Dysmorphol 2008; 17:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/66\">",
"      Mansour S, Hall CM, Pembrey ME, Young ID. A clinical and genetic study of campomelic dysplasia. J Med Genet 1995; 32:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/67\">",
"      Velagaleti GV, Bien-Willner GA, Northup JK, et al. Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia. Am J Hum Genet 2005; 76:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/68\">",
"      Wu MH, Kuo PL, Lin SJ. Prenatal diagnosis of recurrence of short rib-polydactyly syndrome. Am J Med Genet 1995; 55:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/69\">",
"      Whitley CB, Langer LO Jr, Ophoven J, et al. Fibrochondrogenesis: lethal, autosomal recessive chondrodysplasia with distinctive cartilage histopathology. Am J Med Genet 1984; 19:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/70\">",
"      Kulkarni ML, Matadh PS, Praveen Prabhu SP, Kulkarni PM. Fibrochondrogenesis. Indian J Pediatr 2005; 72:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/71\">",
"      Chitayat D, Keating S, Zand DJ, et al. Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases. Am J Med Genet A 2008; 146A:3038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/72\">",
"      Umranikar S, Glanc P, Unger S, et al. X-Linked dominant chondrodysplasia punctata: prenatal diagnosis and autopsy findings. Prenat Diagn 2006; 26:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/37/42585/abstract/73\">",
"      Duff P, Harlass FE, Milligan DA. Prenatal diagnosis of chondrodysplasia punctata by sonography. Obstet Gynecol 1990; 76:497.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14209 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-B869A8C837-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42585=[""].join("\n");
var outline_f41_37_42585=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2348413\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2348162\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2348169\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2348183\">",
"      OVERVIEW OF PRENATAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2348190\">",
"      ULTRASOUND EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33599731\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2348199\">",
"      - Short femur",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33599767\">",
"      Secondary evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2348206\">",
"      - Pattern of limb shortening",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2348213\">",
"      - Qualitative assessment of long bones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33600189\">",
"      - Assessment of other bones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2348227\">",
"      Spine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2348234\">",
"      Hands and feet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2348241\">",
"      Calvarium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2348248\">",
"      Face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2348255\">",
"      Pelvic bones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33600291\">",
"      - Other assessments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2348269\">",
"      ADDITIONAL DIAGNOSTIC TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33600351\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2348276\">",
"      - Three-dimensional ultrasound (3D-US)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33600740\">",
"      - Magnetic resonance imaging (MRI)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2348283\">",
"      - Radiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2348290\">",
"      - Three- dimensional computed tomography (3D-CT)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33600788\">",
"      Invasive procedures for molecular diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33599954\">",
"      COUNSELING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H544667513\">",
"      Prediction of lethality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H544667520\">",
"      Pregnancy management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33601374\">",
"      Postnatal/posttermination evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H454259399\">",
"      - Resources",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2348318\">",
"      SYNOPSIS OF SPECIFIC LETHAL SKELETAL DYSPLASIAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2348325\">",
"      Thanatophoric dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2348332\">",
"      Achondrogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2348339\">",
"      Osteogenesis imperfecta type 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2348346\">",
"      Hypophosphatasia congenita",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2348353\">",
"      Campomelic dysplasia or bent-limb dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2348360\">",
"      Short-rib polydactyly syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2350072\">",
"      Fibrochondrogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2348376\">",
"      Atelosteogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2348383\">",
"      Chondrodysplasia punctata or stippled epiphyses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2348390\">",
"      Other lethal skeletal dysplasias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2350151\">",
"      Variably lethal skeletal dysplasias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2348413\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/14209\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/14209|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?32/16/33027\" title=\"diagnostic image 1\">",
"      Fetal femur length",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?4/26/4515\" title=\"diagnostic image 2\">",
"      Ultrasound of abnormal fetal femur",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?3/39/3697\" title=\"diagnostic image 3\">",
"      Ultrasound of frontal bossing flat nose flat face retrognathia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?25/19/25912\" title=\"diagnostic image 4\">",
"      Ultrasound lethal pulmonary hypoplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?34/7/34930\" title=\"diagnostic image 5\">",
"      Ultrasound of osteogenesis imperfecta type 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?14/60/15302\" title=\"diagnostic image 6\">",
"      Ultrasound of cranium in osteogenesis imperfecta type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/14209|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/17/7453\" title=\"table 1\">",
"      Ultrasound assessment of suspected skeletal dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/33/31259\" title=\"table 2\">",
"      Distinguishing among lethal skeletal dysplasias",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/23/22906?source=related_link\">",
"      Diagnosis of fetal growth restriction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/29/28120?source=related_link\">",
"      Diagnostic imaging procedures during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/9/38040?source=related_link\">",
"      Osteogenesis imperfecta: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/36/26185?source=related_link\">",
"      Osteogenesis imperfecta: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/23/10616?source=related_link\">",
"      Overview of causes of and risk factors for fetal growth restriction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/2/7208?source=related_link\">",
"      Use of array comparative genomic hybridization (aCGH) in obstetrics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_37_42586="Gonococcal skin lesion";
var content_f41_37_42586=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F71303%7EDERM%2F59399%7EDERM%2F69978%7EDERM%2F56764%7EDERM%2F82060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F71303%7EDERM%2F59399%7EDERM%2F69978%7EDERM%2F56764%7EDERM%2F82060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Skin lesions in disseminated gonococcal infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical small pustular skin lesion in a patient with disseminated gonococcal infection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Don L Goldenberg, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 479px\">",
"   <div class=\"ttl\">",
"    Skin lesions in disseminated gonococcal infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 459px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This woman developed a fever, several painful joints, and exquisitely tender necrotic acral pustules. A culture from her cervix grew Neisseria gonorrhoeae.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Skin lesions in disseminated gonococcal infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 367px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A hemorrhagic vesicopustule is present in the web space of this adolescent patient's hand. There is also a pustule on the sole of the foot.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher GR, Ludwig W, Baskin MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Disseminated gonococcal infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This adolescent girl developed a fever and several painful necrotic vesicles and bullae on her arms and legs. A cervical culture was positive for",
"    <em>",
"     Neisseria gonorrhoeae",
"    </em>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Disseminated gonococcal infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This adolescent girl developed tender purpuric papules on her right leg associated with fever and arthralgias. A cervical examination revealed cervical and adnexal tenderness, and a culture was positive for",
"    <em>",
"     Neisseria gonorrhoeae",
"    </em>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42586=[""].join("\n");
var outline_f41_37_42586=null;
var title_f41_37_42587="Isolated chest pain syndromes";
var content_f41_37_42587=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F79217&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F79217&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of isolated musculoskeletal chest pain syndromes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disorder",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical manifestations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Costosternal syndromes (costochondritis)",
"       </td>",
"       <td>",
"        Multiple areas of tenderness that reproduce the described pain, usually in the upper costal cartilages at the costochondral or costosternal junctions; there is no swelling.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tietze's syndrome",
"       </td>",
"       <td>",
"        Painful, nonsuppurative localized swelling of the costosternal, sternoclavicular, or costochondral joints, most often involving one joint in the area of the second and third ribs; rare, primarily affects young adults.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sternalis syndrome",
"       </td>",
"       <td>",
"        Localized tenderness over the body of the sternum or overlying sternalis muscle; palpation often causes radiation of pain bilaterally.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Xiphoidalgia",
"       </td>",
"       <td>",
"        Localized discomfort over the sternum at the xiphoid process.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spontaneous sternoclavicular subluxation",
"       </td>",
"       <td>",
"        Most often occurs in the dominant side, associated with moderate to heavy repetitive tasks; almost exclusively occurs in middle-aged women.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lower rib pain syndromes",
"       </td>",
"       <td>",
"        Pain in the lower chest or upper abdomen with a tender spot on the costal margin; pain can be reproduced by pressing on the spot.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Posterior chest wall syndromes",
"       </td>",
"       <td>",
"        May be caused by herniated thoracic disc, leading to band-like chest pain that may have a unilateral dermatomal distribution. Also induced by costovertebral joint dysfunction; tenderness over the affected area, worse with coughing or deep breathing.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42587=[""].join("\n");
var outline_f41_37_42587=null;
var title_f41_37_42588="Causes septic appearing infant";
var content_f41_37_42588=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of the septic-appearing infant",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bacterial meningitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Sepsis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Urinary tract",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cellulitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Omphalitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mastitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Septic arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Osteomyelitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pertussis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infant botulism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overwhelming viral illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bronchiolitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myocarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflicted head injury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uintentional injury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Neurological",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seizures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Surgical/gastrointestinal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pyloric stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malrotation with volvulus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Incarcerated hernia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Necrotizing enterocolitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Appendicitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cardiac",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Congenital heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cyanotic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Obstructive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Aberrant coronary artery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Supraventricular tachycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Endocrine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital adrenal hyperplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Metabolic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inborn errors of metabolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hematologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute bilirubin encephalopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Toxic exposures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methemaglobinemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbon monoxide poisoning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Apparent life threatening event",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Kawasaki disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42588=[""].join("\n");
var outline_f41_37_42588=null;
var title_f41_37_42589="Thyroid function sick patients";
var content_f41_37_42589=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F61095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F61095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thyroid function tests in nonthyroidal illness",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 439px; height: 254px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the changes in thyroid function tests in patients with nonthyroidal illness of increasing severity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42589=[""].join("\n");
var outline_f41_37_42589=null;
var title_f41_37_42590="SVR dose genotype AASLD";
var content_f41_37_42590=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79643&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79643&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sustained virologic response rates in recipients of peginterferon alfa-2a (pegIFN) and 2 different doses of ribavirin (RBV) for 24 or 48 weeks by hepatitis C virus genotype and viral load",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 449px; height: 357px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from the American Association for the Study of Liver Diseases. Hepatology 2004; 39:1147.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42590=[""].join("\n");
var outline_f41_37_42590=null;
var title_f41_37_42591="Normal fundus";
var content_f41_37_42591=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F66013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F66013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal fundus appearance",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_37_42591=[""].join("\n");
var outline_f41_37_42591=null;
